rfhg_109059.1

Basic information about the TSS

---

TSS ID: rfhg_109059.1 TSS ID(Version3): hg_94080.1 hg_94082.1 hg_94081.1 hg_94079.1 hg_243006.1 Species: human Chr: chr8		Start: 98045384 End: 98045592 Strand: -
Source datasets	ENCODE|PRJNA615891|DRA013844|PRJNA4843412|PRJDB5282 |PRJNA548673|PRJNA597322|PRJNA401781
Protocol	CAGE|SLIC_CAGE|NETCAGE|C1CAGE|ReCappable-seq|TIF-seq2 |STRIPE-seq|RAMPAGE|oligo_capping
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4124179,EH38E2650628)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000518164.5:0 ENST00000521291.5:0 ENST00000396070.6:0 ENST00000518850.5:0 ENST00000287038.8:0 ENST00000523172.5:0 ENST00000517489.1:0 ENST00000520998.1:0 ENST00000521112.1:0 AK308890:0 BC095426:0 L05095:0 AK312102:0 D28438:0 GeneID: 6156 HGNC/MGI_ID: HGNC:10333 UniProt_ID: A0A024R9D3 A0A0B4J213 A0A0C4DH44 E5RJH3 Nearer transcript ids and distances: X79238:17 KJ892036:17 AB591031:17 LF336123:303 MA571700:303 DQ588525:346 view more...

Gene_name: ribosomal protein L30 Gene_symbol: RPL30 Gene_synonyms: L30 Gene_source: HGNC:10333

TATA-Box annotation

---

Distance to TSS:	57
Nearest PromoterID:	NM_000989
Entrez ID:	6156
Nearest Unigene:	Hs.400295
Nearest Refseq:	NM_000989
Nearest Ensembl:	ENSG00000156482
Gene Name:	ribosomal protein L30
Gene Alias:	L30
Gene Type:	protein-coding
CpG%:	0.062500
GC%:	0.574163
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL30 p2@RPL30 p3@RPL30 p4@RPL30 p5@RPL30 p7@RPL30
Sample		p1@RPL30	p2@RPL30	p3@RPL30	p4@RPL30	p5@RPL30	p7@RPL30
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	809.99	5.65	1.75	0.78	0.39	21.43
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	896.47	2.63	1.62	0.61	0.61	18.41
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	941.76	4.05	2.12	0.39	0.00	19.68
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	844.32	2.91	1.46	0.42	0.21	13.72
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	891.09	2.70	1.80	0.22	0.45	17.55
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	957.62	3.49	1.74	0.39	0.19	18.22
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1205.33	5.01	1.31	0.65	0.65	24.62
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	906.14	3.39	0.73	0.48	0.24	23.98
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	826.02	2.14	1.71	1.28	0.00	17.31
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	813.80	1.16	4.64	0.00	0.00	17.39
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	707.41	0.00	4.45	0.81	0.00	12.53
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	614.71	2.44	2.44	0.81	0.00	9.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	994.88	3.39	0.97	2.26	0.16	8.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1028.09	5.26	0.45	2.86	0.15	9.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	958.57	3.07	0.44	0.88	0.44	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1014.01	4.78	0.25	4.02	0.75	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1050.32	2.84	0.66	1.09	0.44	5.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1097.99	1.69	0.00	2.53	0.00	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1112.69	2.67	0.53	1.07	0.00	6.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1239.34	6.32	0.15	2.71	0.45	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1144.73	4.01	0.40	2.54	0.67	7.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1274.48	6.56	0.17	2.93	0.17	10.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1063.01	4.52	0.78	2.07	0.39	6.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1029.64	5.34	0.24	2.91	0.24	8.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1094.13	3.35	0.77	2.32	0.52	6.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1122.98	1.90	0.95	1.58	0.32	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1263.21	4.40	0.55	1.65	0.55	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	784.82	2.59	0.94	1.89	0.47	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1278.94	3.88	0.97	2.91	0.16	8.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1097.01	4.52	1.09	2.90	0.18	10.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1139.88	4.19	0.21	2.72	0.42	9.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1136.73	3.13	0.20	2.15	0.39	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1373.80	6.33	0.63	3.38	0.63	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2149.50	8.08	0.82	2.97	0.16	14.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1282.56	5.98	0.93	2.99	0.00	8.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1014.26	3.07	0.38	1.15	0.77	9.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1174.78	6.54	1.23	2.04	0.61	12.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1055.99	6.25	0.81	3.02	0.20	7.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1145.78	6.48	0.27	2.16	0.54	10.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1018.58	4.56	0.96	3.12	0.00	11.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1050.67	3.53	0.71	2.35	0.47	7.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1331.89	6.59	0.88	2.05	0.15	12.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1265.57	6.33	0.21	3.80	0.21	9.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1082.01	4.90	0.17	3.15	0.35	9.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1035.39	3.41	0.40	3.01	0.60	12.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1047.61	8.84	0.47	5.35	0.70	6.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	949.07	2.16	0.48	2.40	0.00	9.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1118.58	4.77	0.30	2.68	0.30	11.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	971.62	5.51	0.24	3.11	0.24	11.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1126.44	4.04	0.20	2.83	0.20	8.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1054.69	12.09	0.82	0.82	0.61	7.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1143.00	8.01	0.67	1.56	0.22	9.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1665.07	55.97	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	858.76	2.84	0.00	0.35	0.35	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	871.54	4.97	0.33	1.66	0.00	8.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3083.93	23.49	0.84	0.00	1.68	24.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1743.28	16.07	0.92	1.38	0.46	13.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	767.16	8.43	0.00	0.97	0.00	10.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	778.52	1.61	0.64	1.28	0.64	8.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1257.32	14.46	0.31	2.83	0.31	13.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	718.45	3.53	0.00	1.41	2.82	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	702.11	2.80	0.00	0.00	0.00	6.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1068.42	16.72	1.59	3.98	0.00	17.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1065.17	8.83	0.00	3.40	0.34	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	623.20	4.55	0.00	2.60	0.97	5.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	711.38	4.61	0.00	1.06	1.06	6.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1567.90	32.33	0.00	16.16	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1753.24	31.59	0.00	7.90	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	538.22	3.41	0.00	2.44	0.00	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	630.25	2.48	0.00	1.49	0.00	6.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	567.63	2.35	0.94	0.47	0.00	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	689.20	2.98	0.00	1.66	0.33	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	588.06	2.47	0.31	2.17	1.24	6.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	539.94	1.53	0.31	0.92	0.61	7.03
Adipocyte - breast, donor1	11376-118A8	556.24	4.12	0.16	0.32	0.32	4.75
Adipocyte - breast, donor2	11327-117E4	388.87	4.81	0.16	0.16	0.00	3.05
Adipocyte - omental, donor1	11473-119C6	409.16	1.15	0.64	0.25	0.25	4.20
Adipocyte - omental, donor2	11474-119C7	652.56	6.73	0.00	0.75	0.00	5.23
Adipocyte - omental, donor3	11475-119C8	695.63	5.36	0.00	0.67	0.00	5.02
Adipocyte - perirenal, donor1	11476-119C9	818.54	3.83	0.64	1.28	0.00	7.66
Adipocyte - subcutaneous, donor1	11259-116F8	472.79	1.10	0.00	1.10	1.10	5.50
Adipocyte - subcutaneous, donor2	11336-117F4	493.17	3.16	0.00	0.00	0.00	7.68
Adipocyte - subcutaneous, donor3	11408-118E4	609.26	1.74	0.00	0.70	0.00	5.04
Adipocyte differentiation, day04, donor1	13019-139D4	404.44	1.76	0.20	0.20	0.78	3.52
Adipocyte differentiation, day04, donor2	13022-139D7	415.92	1.80	0.00	1.03	0.00	4.63
Adipocyte differentiation, day04, donor3	13025-139E1	426.24	0.84	0.00	0.56	0.28	4.74
Adipocyte differentiation, day04, donor4	13028-139E4	492.59	1.18	0.00	0.00	0.00	3.53
Adipocyte differentiation, day08, donor1	13020-139D5	359.54	0.72	0.16	0.24	0.08	4.18
Adipocyte differentiation, day08, donor2	13023-139D8	545.46	1.94	0.00	0.65	0.00	3.23
Adipocyte differentiation, day08, donor3	13026-139E2	352.44	3.73	0.00	1.07	0.00	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	481.32	1.11	0.56	0.56	0.00	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	388.86	0.42	0.00	0.42	0.00	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	399.86	0.50	0.00	0.00	0.00	2.76
Adipocyte differentiation, day12, donor3	13027-139E3	350.15	1.64	0.00	0.65	0.00	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	263.37	0.91	0.00	0.30	0.00	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	572.16	1.55	0.22	0.00	0.22	9.72
Alveolar Epithelial Cells, donor2	11590-120G6	810.39	2.51	0.36	1.43	0.00	7.17
Alveolar Epithelial Cells, donor3	11671-122G6	753.55	3.59	0.00	0.00	0.00	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	674.29	1.62	0.18	0.18	0.36	5.94
Amniotic Epithelial Cells, donor2	11613-122A2	1122.91	1.67	0.00	0.00	0.00	10.04
Amniotic Epithelial Cells, donor3	11694-123A2	809.26	1.23	0.82	0.82	0.00	7.60
Anulus Pulposus Cell, donor1	11248-116E6	1076.17	2.98	0.34	0.46	0.34	4.00
Anulus Pulposus Cell, donor2	11463-119B5	841.26	4.16	0.24	0.49	0.24	4.41
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	722.92	8.09	0.00	0.45	0.00	6.29
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	755.40	2.17	0.87	0.00	0.43	7.81
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	864.66	6.42	0.00	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	783.18	8.67	0.30	0.00	0.30	5.08
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1020.57	13.91	0.00	2.53	0.00	11.38
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	729.38	6.60	0.66	3.30	0.00	5.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	700.13	6.17	0.32	0.00	0.00	5.20
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	672.82	2.43	0.49	0.49	0.00	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	755.41	10.69	0.59	1.78	0.00	7.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	829.73	6.40	0.75	1.51	0.00	6.03
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	738.01	1.45	0.73	0.73	0.00	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	724.68	6.27	1.25	3.76	0.00	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	722.20	1.65	0.33	0.16	0.16	7.74
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	655.10	5.46	0.00	2.73	0.00	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	758.18	3.92	0.90	1.06	0.45	7.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	746.35	6.97	1.61	0.00	0.00	4.82
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	695.28	4.53	0.57	0.38	0.00	5.10
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	764.97	4.81	0.80	0.80	0.53	7.48
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	619.41	3.90	0.00	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	672.06	4.31	0.00	0.83	0.50	4.81
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	721.63	6.00	0.00	1.20	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	538.10	3.54	0.00	0.00	0.00	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	598.98	2.40	0.51	0.34	0.34	4.63
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	893.53	16.78	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	873.76	5.34	0.49	0.49	0.00	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	538.44	3.04	0.76	0.00	0.00	6.83
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	703.80	9.69	0.00	2.42	0.00	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	816.86	3.99	1.14	0.57	0.00	5.70
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	675.96	2.99	0.21	1.07	0.00	5.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	720.07	3.87	0.52	1.03	0.00	6.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	742.75	3.28	1.41	0.00	0.00	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	658.21	2.25	0.64	0.96	0.32	4.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	794.07	2.85	0.71	2.14	0.00	5.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	791.44	2.92	0.58	0.00	0.00	7.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	694.57	2.71	0.00	0.60	0.30	6.32
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	681.91	5.94	1.19	1.19	0.00	8.32
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	694.18	10.68	0.51	0.00	0.00	9.15
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	540.70	6.37	0.51	1.02	0.00	8.66
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	731.31	3.18	0.00	2.54	0.00	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	738.35	3.45	0.00	0.86	0.00	9.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	694.54	2.33	0.00	0.85	0.64	7.83
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	751.34	2.90	1.74	0.29	0.87	7.25
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	649.98	2.83	0.00	0.00	0.00	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	655.55	1.36	0.17	0.85	0.00	5.93
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	685.64	11.58	2.32	2.32	0.00	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	627.43	4.23	0.00	0.00	0.00	10.56
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	619.01	4.50	0.00	0.21	0.21	6.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	580.61	3.61	1.20	0.60	0.00	4.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	917.05	2.19	0.00	0.00	0.00	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	512.40	4.37	1.61	0.23	0.46	5.29
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	629.92	5.10	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	813.28	2.80	2.29	0.76	0.51	11.69
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	693.84	2.06	0.83	0.62	0.00	5.16
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	528.46	3.98	0.31	0.61	0.92	8.26
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	817.88	10.04	0.48	0.48	0.00	5.74
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	685.18	3.10	0.22	0.44	0.00	4.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	866.65	7.63	0.00	1.53	0.00	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	731.69	3.88	1.11	0.00	1.11	6.09
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	649.81	2.38	0.26	0.00	0.53	6.36
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	558.62	2.54	0.36	2.54	0.00	6.54
Astrocyte - cerebellum, donor1	11500-119F6	842.77	1.23	0.61	0.49	0.61	13.39
Astrocyte - cerebellum, donor2	11580-120F5	957.47	2.05	0.17	0.86	0.00	10.78
Astrocyte - cerebellum, donor3	11661-122F5	1005.53	2.31	0.42	0.63	0.00	5.87
Astrocyte - cerebral cortex, donor1	11235-116D2	932.81	2.79	0.70	0.00	1.05	9.76
Astrocyte - cerebral cortex, donor2	11316-117D2	572.84	4.04	0.81	0.65	0.00	12.13
Astrocyte - cerebral cortex, donor3	11392-118C6	603.80	1.34	0.30	1.04	0.00	12.08
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	737.77	3.21	0.46	0.23	0.69	5.85
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	715.86	1.75	0.75	0.25	0.13	7.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	683.12	1.25	0.23	0.23	0.23	7.17
Basophils, donor1	12241-129G9	1664.13	2.09	0.78	0.52	0.26	3.92
Basophils, donor2	12242-129H1	2477.94	5.41	2.16	0.36	0.00	3.25
Basophils, donor3	12243-129H2	910.79	1.62	0.15	0.44	0.59	3.67
Bronchial Epithelial Cell, donor1	11511-119G8	860.69	3.45	0.86	0.22	0.22	3.88
Bronchial Epithelial Cell, donor2	11591-120G7	503.36	0.00	0.00	0.00	0.00	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	1248.20	7.17	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	643.34	4.39	1.26	0.00	0.00	15.69
Bronchial Epithelial Cell, donor5	11457-119A8	353.72	1.04	0.42	0.21	0.00	10.19
Bronchial Epithelial Cell, donor6	11461-119B3	471.87	2.07	1.15	0.69	0.00	8.06
Bronchial Epithelial Cell, donor7	11769-123I5	877.23	5.58	0.18	1.26	0.72	6.12
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1656.51	2.58	0.00	0.21	0.41	15.36
Burkitt's lymphoma cell line:RAJI	10476-106I8	2206.53	5.36	0.93	0.23	2.79	22.13
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	5237.91	7.35	1.28	1.92	0.32	14.07
CD133+ stem cells - cord blood derived, pool1	12223-129E9	6349.95	10.34	10.34	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	1215.03	1.13	0.00	0.56	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	844.48	2.04	0.74	0.56	0.56	2.41
CD14+ Monocytes, donor3	11381-118B4	1063.43	2.41	0.44	2.41	0.44	2.63
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1007.92	2.83	0.00	0.57	0.28	2.83
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	847.23	2.65	0.00	0.00	2.27	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	650.58	1.97	0.00	0.33	0.66	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	977.58	6.94	0.14	1.59	0.00	2.89
CD14+ monocytes - mock treated, donor2	11873-125C1	830.70	6.34	0.00	1.81	0.00	3.92
CD14+ monocytes - mock treated, donor3	11883-125D2	816.81	4.50	0.00	1.42	1.18	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	777.90	4.18	0.17	1.17	0.17	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	711.28	4.69	0.00	1.38	0.28	4.42
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	637.43	5.70	0.25	0.99	0.25	4.46
CD14+ monocytes - treated with BCG, donor1	11860-125A6	816.49	5.09	0.00	0.98	0.00	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1006.87	5.70	0.36	0.71	0.36	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1710.79	14.15	0.44	1.52	0.44	3.92
CD14+ monocytes - treated with Candida, donor1	11868-125B5	915.44	2.58	0.23	2.11	0.23	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1000.09	4.75	0.00	3.17	0.00	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1164.83	4.44	0.00	0.00	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	865.87	5.65	0.30	1.64	0.15	3.72
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	851.47	8.58	0.20	1.40	0.00	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1654.35	11.45	0.21	0.42	0.42	7.70
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1060.42	6.86	0.23	2.06	0.46	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1003.44	4.52	0.00	0.00	1.13	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	876.41	6.55	0.44	0.87	0.00	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	847.05	7.80	0.81	0.81	0.81	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1094.39	8.72	0.35	1.05	0.35	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	958.21	9.68	0.42	2.10	0.42	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	963.93	4.78	0.00	0.37	0.18	3.49
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	730.95	4.23	0.00	0.70	0.00	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	768.21	6.14	0.00	1.32	0.44	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	815.37	5.93	0.00	0.87	0.70	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	899.83	7.81	0.00	2.23	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1643.56	9.05	0.00	0.65	0.65	3.66
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	808.33	2.87	0.00	1.64	0.82	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1079.95	4.64	0.00	0.46	0.00	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1417.93	9.05	0.23	1.39	0.46	3.25
CD14+CD16+ Monocytes, donor1	11789-124B7	1691.40	9.15	0.22	0.44	0.65	3.92
CD14+CD16+ Monocytes, donor2	11801-124D1	1843.57	8.78	0.69	1.62	0.23	3.93
CD14+CD16+ Monocytes, donor3	11912-125G4	1968.82	5.42	0.65	0.87	0.43	4.55
CD14+CD16- Monocytes, donor1	11788-124B6	1906.04	6.23	0.16	1.25	0.31	3.58
CD14+CD16- Monocytes, donor2	11799-124C8	1631.00	4.37	0.17	0.17	0.17	2.62
CD14+CD16- Monocytes, donor3	11910-125G2	1054.87	6.24	0.00	0.22	1.11	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	2556.85	4.34	0.00	0.26	0.26	4.59
CD14-CD16+ Monocytes, donor2	11800-124C9	1722.71	8.78	0.22	1.10	0.44	3.51
CD14-CD16+ Monocytes, donor3	11911-125G3	1957.87	5.90	0.84	0.21	0.00	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8015.43	24.39	0.00	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8070.66	14.24	0.68	2.03	0.00	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	8913.39	15.53	0.00	3.11	0.00	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8842.03	5.86	1.60	1.07	0.53	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	8732.00	14.47	0.54	4.29	1.07	8.58
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7877.85	14.04	0.00	0.70	0.00	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8579.27	16.47	0.00	1.57	0.00	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10980.00	21.09	1.32	2.64	0.00	6.59
CD19+ B Cells, donor1	11544-120B5	2688.44	8.22	1.64	6.58	0.00	3.29
CD19+ B Cells, donor2	11624-122B4	2606.46	9.43	2.18	2.18	0.73	5.80
CD19+ B Cells, donor3	11705-123B4	2369.15	10.10	1.51	4.04	0.50	5.05
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1207.32	2.83	2.02	0.81	0.00	10.10
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1067.44	2.80	1.60	0.40	0.00	15.58
CD34+ Progenitors, donor1	11545-120B6	3766.18	2.01	1.00	0.00	0.00	6.02
CD34+ Progenitors, donor2	11625-122B5	4844.47	7.30	1.69	0.00	0.56	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2700.18	7.89	0.00	1.50	1.50	16.16
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	4101.09	8.79	0.45	0.00	0.45	13.75
CD4+ T Cells, donor1	11225-116C1	3982.61	4.28	6.43	1.07	2.86	5.36
CD4+ T Cells, donor2	11306-117C1	4345.94	28.17	10.41	1.22	3.67	4.29
CD4+ T Cells, donor3	11382-118B5	3661.14	10.98	2.13	6.10	0.91	4.27
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2364.26	7.40	1.28	1.53	1.28	3.06
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2268.66	2.92	2.47	1.35	2.47	2.92
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	2264.62	4.89	4.02	1.72	2.30	2.87
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	9400.75	17.07	5.69	1.42	0.95	6.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11969.67	20.37	7.02	2.81	0.00	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	7479.13	36.26	6.59	19.78	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1397.03	3.90	3.76	0.43	0.29	2.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1354.01	5.76	3.39	1.02	0.85	4.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1242.25	4.03	3.39	0.48	0.48	3.39
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4795.90	10.76	2.24	3.59	0.90	5.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5081.85	19.92	4.19	2.10	1.75	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3457.81	12.76	3.96	0.00	0.88	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2467.02	4.64	5.06	1.69	0.84	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1848.53	4.99	4.36	1.66	0.83	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2190.21	7.02	4.68	3.01	1.67	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	6977.84	17.95	3.81	2.18	2.72	4.62
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8646.47	26.26	4.82	5.36	0.54	7.50
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	6111.32	19.73	10.76	12.55	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1849.83	4.08	4.45	1.11	0.37	3.34
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1465.42	4.98	2.82	0.87	2.17	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1241.16	5.46	3.78	0.63	1.68	3.57
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6612.80	12.13	5.56	1.01	0.00	8.60
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6184.66	15.60	3.47	1.73	0.87	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5012.31	26.15	3.92	1.31	2.61	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10658.00	20.29	3.46	6.43	1.98	5.94
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	11425.34	11.08	4.62	3.69	0.92	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13083.05	18.15	8.37	4.19	0.00	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9217.29	19.94	0.83	0.83	0.28	8.03
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	9389.64	14.72	1.47	0.25	0.00	5.64
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9327.82	9.24	0.00	0.00	1.54	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	7921.56	17.55	3.58	2.86	0.72	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11721.18	18.00	6.92	2.77	0.00	8.31
CD8+ T Cells, donor1	11226-116C2	3354.50	4.58	6.88	0.98	0.98	4.91
CD8+ T Cells, donor2	11307-117C2	2503.38	12.39	5.63	2.25	0.75	4.13
CD8+ T Cells, donor3	11383-118B6	3532.58	12.37	7.32	6.82	0.50	6.31
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	775.34	2.06	0.69	0.46	0.23	5.28
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	733.79	1.44	0.72	0.72	0.24	4.55
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	892.18	3.01	0.55	0.82	0.00	4.10
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1069.65	3.60	3.00	1.50	0.00	5.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	694.99	2.40	1.92	0.72	0.00	3.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	711.49	1.59	0.68	0.68	0.00	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	638.16	3.69	1.30	0.65	0.00	7.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	724.34	0.79	1.84	0.79	0.00	7.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	711.75	0.47	0.70	0.47	0.23	6.80
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	864.27	3.02	1.81	1.51	0.30	8.75
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	841.30	1.74	2.03	0.29	0.58	11.62
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	789.18	3.73	1.07	1.07	0.00	5.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	506.92	0.44	0.44	0.44	0.00	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	570.65	1.37	1.82	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	494.51	0.75	0.00	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	739.04	1.80	0.72	1.08	0.00	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	710.96	0.58	1.15	0.86	0.00	5.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	698.60	0.94	1.89	0.71	0.00	3.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	552.36	1.27	0.63	0.63	0.00	7.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	831.04	1.85	1.23	0.92	0.00	3.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	713.30	0.64	1.92	0.64	0.00	8.01
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	835.31	2.29	1.91	0.38	0.00	6.88
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	722.79	0.39	1.97	0.00	0.00	9.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	778.35	0.76	0.76	0.00	0.00	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	680.10	4.01	0.80	0.00	0.80	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	749.79	2.10	0.00	0.70	0.70	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	425.74	1.00	2.00	0.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	137.08	1.83	3.66	0.00	1.83	7.31
Cardiac Myocyte, donor2	11605-120I3	761.39	1.98	0.00	0.99	0.00	6.42
Cardiac Myocyte, donor3	11686-122I3	797.77	1.47	0.00	0.21	0.00	10.52
Chondrocyte - de diff, donor1	11261-116G1	755.73	2.43	0.69	0.35	1.73	7.97
Chondrocyte - de diff, donor2	11338-117F6	533.78	1.78	0.36	0.00	0.00	5.33
Chondrocyte - de diff, donor3	11410-118E6	802.82	2.84	0.11	0.46	0.23	6.26
Chondrocyte - re diff, donor2	11339-117F7	262.31	0.90	0.00	0.90	0.00	6.27
Chondrocyte - re diff, donor3	11411-118E7	688.70	1.62	0.81	0.40	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	1026.86	3.79	1.15	0.57	0.23	11.93
Ciliary Epithelial Cells, donor2	11323-117D9	720.82	3.63	1.07	0.86	0.21	11.33
Ciliary Epithelial Cells, donor3	11399-118D4	646.56	2.21	1.42	0.53	0.09	11.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	584.13	0.92	3.85	0.09	0.09	2.29
Corneal Epithelial Cells, donor1	11526-119I5	671.89	0.88	0.44	0.00	0.22	3.73
Corneal Epithelial Cells, donor2	11606-120I4	930.56	2.28	0.00	0.00	0.00	13.65
Corneal Epithelial Cells, donor3	11687-122I4	849.46	3.83	0.00	1.28	0.00	14.83
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	388.63	1.49	0.00	0.17	0.50	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	571.21	2.21	0.00	0.00	0.00	4.73
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	724.65	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	383.69	1.51	0.22	0.76	0.11	1.84
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2292.76	5.47	3.42	1.37	0.68	4.10
Dendritic Cells - plasmacytoid, donor2	11309-117C4	4206.44	7.83	0.65	1.96	0.00	7.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3767.99	8.23	1.45	0.48	0.48	5.81
Endothelial Cells - Aortic, donor0	11207-116A1	556.17	0.33	0.17	0.00	0.00	8.84
Endothelial Cells - Aortic, donor1	11263-116G3	501.11	1.17	0.59	1.76	0.00	8.21
Endothelial Cells - Aortic, donor2	11340-117F8	486.41	1.70	0.00	0.85	0.00	6.22
Endothelial Cells - Aortic, donor3	11412-118E8	530.41	0.00	0.39	0.79	0.00	6.29
Endothelial Cells - Artery, donor1	11264-116G4	512.52	3.49	0.58	0.58	0.29	9.60
Endothelial Cells - Artery, donor2	11341-117F9	363.50	1.88	0.47	0.94	0.00	7.53
Endothelial Cells - Artery, donor3	11413-118E9	433.19	1.05	0.18	0.35	0.00	7.36
Endothelial Cells - Lymphatic, donor1	11236-116D3	731.45	4.21	0.00	0.22	0.44	3.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	419.89	0.61	0.61	0.91	0.30	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	361.40	0.00	0.28	0.00	1.13	3.95
Endothelial Cells - Microvascular, donor1	11265-116G5	828.11	1.78	0.30	0.00	0.89	3.86
Endothelial Cells - Microvascular, donor2	11342-117G1	576.38	3.64	1.56	1.56	2.08	10.93
Endothelial Cells - Microvascular, donor3	11414-118F1	653.92	1.13	0.00	1.13	0.14	3.69
Endothelial Cells - Thoracic, donor1	11266-116G6	728.22	2.80	0.40	0.40	1.20	11.20
Endothelial Cells - Thoracic, donor2	11343-117G2	482.72	1.05	0.52	0.00	0.00	5.24
Endothelial Cells - Umbilical vein, donor1	11243-116E1	765.61	2.48	0.00	0.25	0.62	10.81
Endothelial Cells - Umbilical vein, donor2	11324-117E1	514.26	0.65	0.00	0.22	0.87	13.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	483.01	0.49	0.00	0.37	0.00	10.38
Endothelial Cells - Vein, donor1	11267-116G7	426.57	2.28	0.00	1.14	0.00	22.75
Endothelial Cells - Vein, donor2	11344-117G3	296.16	0.00	0.70	0.00	0.00	5.59
Endothelial Cells - Vein, donor3	11416-118F3	573.86	0.63	0.16	1.26	0.00	10.21
Eosinophils, donor1	12244-129H3	3613.52	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1123.83	0.00	0.00	0.00	0.00	4.95
Eosinophils, donor3	12246-129H5	970.18	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	662.61	1.47	0.49	0.73	0.00	4.89
Esophageal Epithelial Cells, donor2	11587-120G3	1285.54	4.16	0.00	0.00	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	1106.28	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	584.57	3.69	0.41	2.05	0.41	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	476.17	7.23	0.77	4.60	1.97	5.69
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1064.64	5.42	0.43	1.63	0.00	11.48
Fibroblast - Aortic Adventitial, donor1	11245-116E3	614.28	5.09	0.49	0.24	0.24	12.01
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	131.83	0.14	0.27	0.00	0.00	8.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	498.34	2.74	0.21	0.32	0.11	5.80
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	223.70	1.32	0.00	0.26	0.00	4.22
Fibroblast - Aortic Adventitial, donor3	11401-118D6	470.73	3.99	0.33	0.33	0.33	8.30
Fibroblast - Cardiac, donor1	11268-116G8	643.24	5.90	0.45	0.91	0.00	12.25
Fibroblast - Cardiac, donor2	11345-117G4	450.22	5.31	1.52	0.76	2.27	9.10
Fibroblast - Cardiac, donor3	11417-118F4	346.66	3.63	0.63	0.63	0.00	8.36
Fibroblast - Cardiac, donor4	11452-119A3	337.36	0.61	0.30	1.21	0.00	5.46
Fibroblast - Cardiac, donor5	11456-119A7	693.28	1.90	0.25	0.38	0.00	9.39
Fibroblast - Cardiac, donor6	11460-119B2	726.74	4.09	0.45	0.61	0.15	13.95
Fibroblast - Choroid Plexus, donor1	11492-119E7	736.55	1.34	0.13	0.54	0.80	5.09
Fibroblast - Choroid Plexus, donor2	11572-120E6	636.79	1.73	0.00	0.43	0.00	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	656.23	1.46	0.00	0.00	2.93	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	620.65	0.69	0.69	0.00	0.46	5.07
Fibroblast - Conjunctival, donor3	11692-122I9	1207.92	3.39	0.00	0.34	1.36	2.04
Fibroblast - Dermal, donor1	11269-116G9	621.23	3.29	0.00	0.47	0.00	11.27
Fibroblast - Dermal, donor2	11346-117G5	466.02	2.83	0.00	0.47	0.47	10.85
Fibroblast - Dermal, donor3	11418-118F5	799.42	2.78	0.12	1.33	0.12	7.98
Fibroblast - Dermal, donor4	11450-119A1	605.58	3.50	0.11	0.34	0.00	10.29
Fibroblast - Dermal, donor5	11454-119A5	838.42	4.01	0.52	0.52	0.00	13.08
Fibroblast - Dermal, donor6	11458-119A9	803.35	4.55	0.16	0.49	0.00	17.54
Fibroblast - Gingival, donor1	11237-116D4	661.75	1.67	0.21	0.00	0.21	4.79
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	491.77	1.83	0.26	0.52	0.00	7.86
Fibroblast - Gingival, donor2	11318-117D4	728.50	3.95	0.26	0.53	0.13	12.39
Fibroblast - Gingival, donor3	11394-118C8	530.23	0.77	0.10	0.48	0.00	3.38
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	464.38	3.12	1.04	0.00	0.00	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	426.24	1.76	0.18	0.18	0.18	3.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	396.44	0.94	1.25	0.16	0.16	12.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	563.22	2.16	0.68	0.41	0.00	8.65
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	53.99	0.00	0.71	0.00	0.00	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	580.59	0.88	0.15	0.58	0.15	11.11
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	579.77	2.59	0.41	1.09	0.27	13.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	658.16	2.74	0.33	0.55	0.11	19.20
Fibroblast - Gingival, donor9 (control)	11927-125I1	611.17	3.08	0.44	0.44	0.15	3.37
Fibroblast - Lung, donor1	11270-116H1	386.06	1.36	0.00	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	493.90	4.48	1.49	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	518.73	2.32	0.42	1.27	0.00	9.50
Fibroblast - Lymphatic, donor1	11506-119G3	460.66	0.00	1.67	0.00	0.00	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	551.06	0.00	0.00	0.00	0.00	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	404.70	0.56	0.00	0.56	0.00	2.24
Fibroblast - Mammary, donor1	11540-120B1	435.20	0.00	0.41	0.00	0.00	6.09
Fibroblast - Mammary, donor2	11620-122A9	754.91	3.99	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	929.18	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	938.83	1.94	0.58	0.58	0.19	8.53
Fibroblast - Periodontal Ligament, donor2	11319-117D5	378.60	2.58	0.30	0.15	0.30	5.01
Fibroblast - Periodontal Ligament, donor3	11395-118C9	244.79	0.00	0.00	0.31	0.00	3.06
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	440.39	2.67	0.38	0.00	0.00	11.07
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	630.70	5.13	0.00	0.54	0.00	10.53
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	358.36	0.93	0.23	1.51	0.00	4.29
Fibroblast - Pulmonary Artery, donor1	11250-116E8	839.83	3.32	1.22	0.44	0.33	18.35
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	378.54	0.20	1.42	0.41	0.20	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	797.17	2.00	0.00	0.67	0.00	10.02
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	848.84	1.98	0.40	1.98	0.00	5.54
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	223.25	0.99	0.00	0.20	0.00	8.53
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	800.35	1.95	0.89	0.36	0.36	2.66
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	795.83	1.77	0.39	0.20	0.59	3.74
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	222.63	1.50	0.30	0.00	0.00	9.03
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	890.71	3.67	0.11	0.11	0.22	7.99
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	185.00	1.27	0.25	0.25	0.00	5.31
Fibroblast - skin normal, donor1	11553-120C5	734.09	2.46	0.66	0.00	0.82	5.09
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	145.17	0.20	0.20	0.20	0.00	7.02
Fibroblast - skin normal, donor2	11561-120D4	692.18	3.11	0.60	0.10	0.00	4.52
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	217.31	1.81	0.60	0.00	0.00	9.07
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	854.56	1.16	0.58	0.08	1.74	3.89
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	1451.20	4.10	0.17	0.17	0.00	4.79
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	188.19	0.00	0.66	0.00	0.00	3.61
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	655.75	2.24	0.32	0.00	0.11	8.84
Fibroblast - skin walker warburg, donor1	11554-120C6	591.23	2.02	0.67	0.17	0.51	7.76
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1613.83	11.45	0.47	0.78	0.16	11.76
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2925.09	22.16	0.00	0.00	0.00	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1024.92	5.23	0.00	0.87	3.49	7.84
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	515.22	1.73	0.87	0.35	0.17	6.76
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	455.16	0.52	1.56	0.52	0.00	9.89
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	345.45	0.51	1.53	0.00	0.00	7.15
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1243.26	4.59	7.66	1.53	0.77	57.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1588.80	15.31	5.10	1.91	1.91	70.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1828.83	18.83	3.99	2.00	0.29	107.26
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1542.31	19.85	1.93	1.93	1.10	13.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	780.19	5.25	3.20	1.83	0.00	16.67
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1240.69	9.91	1.19	2.18	0.20	63.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1445.38	23.00	2.11	1.06	1.06	14.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	711.33	8.81	1.63	0.65	0.33	10.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1973.20	9.73	3.98	1.33	0.44	90.66
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1299.18	7.63	1.55	0.85	0.14	25.58
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	1039.32	2.71	0.99	1.23	0.25	13.30
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	843.21	2.42	1.88	0.81	0.00	31.43
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	920.53	2.11	1.24	0.50	0.12	12.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1030.03	3.46	1.38	1.11	0.14	15.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	784.55	7.32	0.61	1.63	0.20	23.18
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	720.36	2.97	0.46	1.14	0.23	9.13
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	898.74	2.87	0.87	0.62	0.00	7.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	559.12	1.53	1.31	1.31	0.22	11.37
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	747.56	3.84	0.89	1.18	0.00	10.93
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	994.28	3.18	2.38	0.64	0.00	8.42
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	698.19	1.12	1.56	0.22	0.00	7.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	775.68	2.42	1.01	1.61	0.00	9.28
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1006.49	3.90	0.85	1.19	0.17	11.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	652.80	0.89	1.15	0.18	0.18	11.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	830.16	0.83	0.42	0.42	0.10	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	746.29	1.02	0.51	0.34	0.34	4.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1054.75	2.88	0.66	0.77	0.33	9.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	753.51	1.33	0.75	0.08	0.33	9.40
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	726.68	0.61	0.82	0.61	0.00	11.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	817.80	4.33	0.83	0.83	0.00	9.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1066.58	3.57	0.69	0.81	0.23	6.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	640.71	1.50	0.83	0.50	0.17	10.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	833.89	1.76	0.44	0.66	0.22	5.73
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1307.28	4.55	0.37	1.23	0.25	7.63
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	409.77	1.30	0.81	0.65	0.49	10.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1069.26	3.53	0.32	0.32	0.00	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	884.63	2.46	0.19	0.66	0.00	5.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	661.65	1.58	0.00	1.11	0.16	8.23
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	430.59	2.13	0.30	0.30	0.00	8.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	907.08	2.30	0.42	0.63	0.00	10.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	688.30	2.85	0.88	1.10	0.00	6.15
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	728.58	1.12	0.84	1.40	0.00	10.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	434.05	1.85	0.37	0.46	0.00	7.13
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	281.04	2.67	0.27	1.60	0.53	11.50
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	381.29	1.07	0.61	0.00	0.15	12.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	584.47	1.30	1.04	0.00	0.00	9.97
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	456.76	1.63	0.00	1.08	0.00	6.78
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	560.24	1.11	0.74	0.92	0.00	7.93
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	399.59	2.41	0.22	0.44	0.00	5.48
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	232.07	0.00	0.00	0.99	0.00	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	453.38	1.58	0.79	0.53	0.13	5.67
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	518.31	1.61	0.61	0.20	0.00	3.63
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	261.53	0.25	0.25	0.25	0.00	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1181.22	3.98	1.99	1.59	1.39	43.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1160.66	3.08	2.62	0.77	0.31	23.42
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1279.67	5.11	1.84	0.82	0.00	38.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1191.64	4.07	2.82	2.19	4.69	81.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1546.14	8.48	3.39	5.93	5.09	88.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1058.47	9.22	1.38	1.84	1.38	55.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1561.60	12.37	4.95	2.47	2.47	42.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1204.91	10.06	3.87	1.55	0.00	47.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1543.50	12.84	4.81	1.60	3.21	49.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	862.46	8.69	5.22	5.22	0.00	29.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1271.00	10.74	4.88	0.98	0.00	38.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1217.29	9.47	4.12	2.47	0.00	44.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1069.66	16.66	0.00	6.66	0.00	29.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1208.36	9.79	3.08	3.08	0.56	34.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1011.58	5.88	3.27	1.31	0.33	35.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	858.97	13.42	2.52	3.36	1.68	24.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1293.60	5.09	2.54	1.91	0.32	26.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1236.03	7.47	3.06	1.02	0.68	35.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2006.71	10.44	0.00	0.00	0.00	41.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1916.25	12.60	1.72	1.72	0.00	24.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1243.42	9.47	2.66	1.48	0.30	20.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1555.22	20.33	3.39	1.69	1.69	30.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1424.05	17.81	5.38	2.49	0.00	39.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1173.43	6.21	4.60	1.38	0.46	28.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1359.27	36.88	0.00	10.54	0.00	36.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1140.17	11.53	1.15	1.54	0.00	29.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1298.99	8.15	2.28	1.96	0.33	21.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	2019.23	18.73	0.67	6.69	2.01	18.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1673.22	14.25	2.31	2.31	0.39	10.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1230.71	6.85	6.85	1.37	0.34	23.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1555.48	29.82	0.00	4.97	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2187.03	14.16	1.89	3.30	0.00	10.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1858.16	16.90	0.60	2.41	0.60	14.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1523.48	9.66	0.51	7.12	1.53	15.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1902.46	12.76	1.20	2.39	0.40	18.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2169.78	17.76	0.49	2.96	0.49	21.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2312.48	50.76	2.36	10.62	4.72	15.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2103.32	14.59	1.17	4.67	0.58	12.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	2007.01	10.97	0.44	3.07	0.44	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1476.68	19.50	0.85	1.70	0.00	13.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1101.31	13.73	3.58	1.79	0.00	20.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1597.92	18.92	1.94	2.91	0.97	29.60
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	474.78	1.14	1.14	1.14	0.00	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	313.53	0.83	0.42	0.00	0.00	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	404.80	0.00	1.12	2.25	0.00	11.24
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	839.53	4.76	0.63	0.00	1.27	4.44
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	971.67	5.01	0.42	0.84	0.00	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	889.69	4.87	1.62	0.81	0.23	19.50
Hep-2 cells mock treated, biol_rep2	11899-125E9	742.39	4.05	2.53	2.19	0.17	19.92
Hep-2 cells mock treated, biol_rep3	11900-125F1	723.92	2.05	2.73	1.59	0.00	20.02
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	911.75	5.14	1.97	1.09	0.44	23.06
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	708.78	4.51	2.36	2.58	0.21	15.47
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	713.23	3.01	2.15	0.65	0.22	15.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1039.76	3.24	1.74	1.62	0.00	21.79
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	809.37	3.95	1.03	1.54	0.17	22.13
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	767.93	4.16	2.56	1.60	0.32	18.90
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	759.97	0.56	0.00	0.00	0.00	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	701.13	0.43	0.43	0.43	0.00	4.33
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	816.94	2.64	0.00	0.00	0.00	21.15
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	705.80	0.71	0.00	0.71	0.00	8.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	888.52	2.18	0.00	0.73	0.00	9.44
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	675.58	3.32	0.70	0.87	0.35	18.18
Hepatocyte, donor1	11523-119I2	566.56	4.84	1.21	0.00	0.00	10.90
Hepatocyte, donor2	11603-120I1	579.61	4.31	2.15	0.00	3.23	7.54
Hepatocyte, donor3	11684-122I1	550.34	1.23	1.23	1.84	0.61	8.59
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2043.56	20.23	6.53	3.92	1.31	40.47
Intestinal epithelial cells (polarized), donor1	11246-116E4	702.45	3.50	0.52	0.87	0.35	6.12
Iris Pigment Epithelial Cells, donor1	11530-119I9	523.99	0.82	0.55	0.55	0.27	9.06
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	289.73	0.00	3.18	0.00	0.00	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	320.41	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	541.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	294.87	0.00	1.38	0.00	1.38	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	322.84	0.00	2.50	0.00	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	415.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	205.03	0.00	0.00	0.00	0.00	17.94
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	329.10	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	393.09	4.87	0.00	0.00	3.25	9.75
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	325.12	3.33	0.00	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	290.45	0.00	0.00	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	353.37	3.97	0.00	0.00	0.00	9.26
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	356.98	1.11	1.11	1.11	0.00	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	455.73	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	575.07	1.26	0.00	0.63	0.00	5.67
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	327.88	0.00	1.55	0.00	0.00	10.83
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	336.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	549.13	1.29	0.65	0.00	0.00	7.11
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	233.44	0.00	0.00	0.00	0.00	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	394.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	557.38	0.00	0.00	0.00	0.00	8.15
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	233.41	0.00	0.00	0.42	0.00	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	330.57	0.00	0.00	0.00	0.00	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	541.68	1.61	0.80	0.00	0.00	8.84
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	321.30	2.77	0.00	0.00	0.00	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	211.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	570.69	4.25	0.94	0.47	0.00	7.55
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	362.79	4.53	0.00	0.91	0.00	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	427.53	0.00	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	546.67	2.15	2.15	0.00	0.00	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	309.99	0.00	2.54	1.27	0.00	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	410.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	404.29	3.19	0.00	0.00	0.00	7.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	251.53	1.82	0.00	1.82	0.00	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	426.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	382.74	2.14	0.00	0.00	0.00	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	275.42	3.32	0.00	0.00	0.00	9.95
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	604.05	3.09	0.00	0.31	0.00	5.25
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	265.16	1.76	0.00	0.00	0.00	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	352.03	3.14	0.00	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	371.34	1.39	0.00	0.00	0.00	4.87
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	312.05	2.21	2.21	0.00	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	424.70	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	407.19	0.87	1.74	0.00	0.00	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	285.72	0.00	0.00	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	233.47	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	502.45	1.07	1.07	0.00	0.00	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	292.33	0.00	0.00	0.00	0.00	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	233.67	0.00	0.00	0.00	0.00	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	353.44	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	296.48	3.03	0.00	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	316.64	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	547.72	3.17	0.00	1.06	0.00	3.17
Keratinocyte - epidermal, donor1	11272-116H3	326.89	0.65	0.33	0.08	0.82	4.49
Keratinocyte - epidermal, donor2	11349-117G8	288.13	1.17	0.59	0.00	0.00	8.20
Keratinocyte - epidermal, donor3	11421-118F8	709.92	2.56	0.76	1.51	0.09	12.21
Keratinocyte - oral, donor1	11251-116E9	1125.30	3.18	1.36	0.57	0.23	7.61
Keratocytes, donor1	11527-119I6	878.15	1.38	1.03	0.69	0.69	13.75
Keratocytes, donor2	11607-120I5	685.50	1.17	0.00	0.00	0.00	10.55
Keratocytes, donor3	11688-122I5	890.57	3.36	0.00	1.98	0.59	4.94
Krukenberg tumor cell line:HSKTC	10687-109F3	145.06	0.00	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	486.51	5.39	0.00	0.00	0.00	6.47
Lens Epithelial Cells, donor2	11609-120I7	815.28	0.69	1.38	0.12	0.00	5.07
Lens Epithelial Cells, donor3	11690-122I7	424.02	0.50	1.72	0.30	0.10	6.96
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	727.23	1.78	0.71	0.95	2.13	6.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	788.39	1.40	1.12	0.56	0.28	8.09
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	810.99	4.56	0.31	0.63	0.16	9.29
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	765.71	5.38	1.08	0.54	0.00	7.53
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	785.39	4.10	0.32	0.95	0.32	6.93
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	846.34	4.53	0.54	0.32	0.11	7.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	710.39	0.82	0.41	0.00	0.41	5.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	851.24	2.53	0.51	0.51	0.51	6.83
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	755.13	2.53	0.84	1.13	0.14	6.33
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	787.11	1.98	0.79	0.40	0.00	7.91
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	847.08	1.55	0.19	0.19	0.00	5.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	818.17	3.52	0.56	1.48	0.19	6.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	827.51	1.74	0.00	0.70	0.00	7.32
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	757.79	1.19	0.00	0.00	0.00	8.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	805.68	2.33	0.27	0.55	0.00	7.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	793.92	1.85	0.00	0.00	0.62	5.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	779.98	3.12	0.00	0.62	0.62	8.42
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	786.68	1.46	0.37	0.37	0.55	4.94
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	766.50	2.63	0.66	0.00	0.00	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	845.81	2.64	0.88	1.17	0.00	9.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	810.76	3.49	0.00	0.50	0.25	5.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	781.28	1.45	0.00	0.48	0.00	12.61
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	904.03	1.62	0.54	0.54	0.27	7.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	899.49	3.78	0.30	0.30	0.00	7.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	850.71	2.59	0.00	0.00	0.00	8.81
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	801.34	2.93	0.21	0.84	0.42	6.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	780.73	2.41	0.60	0.75	0.30	9.17
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	865.35	4.13	0.69	1.38	0.00	7.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	794.74	2.45	0.00	0.94	0.00	5.46
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	788.86	4.03	0.64	0.74	0.11	7.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	763.69	2.42	0.00	0.48	0.00	9.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	774.05	1.65	0.33	0.99	0.00	7.28
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	754.75	2.48	0.25	0.74	0.25	7.43
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	694.51	4.44	0.00	0.00	0.00	6.66
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	786.22	2.47	0.00	1.73	0.49	6.92
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	738.20	2.20	0.27	0.69	0.14	7.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	782.22	2.57	0.00	0.96	0.00	5.15
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	780.91	0.61	1.22	1.22	0.00	10.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	824.82	2.52	0.84	0.84	0.28	7.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	910.59	1.07	0.36	0.00	0.00	7.47
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	851.27	0.97	0.00	1.45	0.00	4.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	742.09	2.80	0.47	0.62	0.00	5.45
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	882.01	5.01	0.00	0.72	0.00	5.73
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	781.08	3.27	0.00	0.00	0.00	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	829.63	2.83	0.24	0.71	0.24	8.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	683.48	1.86	0.37	0.25	1.24	6.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	727.15	1.54	0.00	0.00	0.51	4.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	722.62	2.98	0.00	0.90	0.00	8.65
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2109.65	0.00	0.00	0.00	2.27	29.46
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1500.51	3.84	1.53	5.37	0.00	20.71
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1642.55	3.71	1.48	0.74	0.00	25.24
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1913.39	14.81	1.27	4.65	0.42	24.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1621.16	9.14	3.52	2.11	0.70	13.36
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1720.36	6.54	2.80	2.80	0.00	23.35
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1858.06	30.40	5.15	3.61	0.00	19.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1614.10	14.27	3.57	4.76	0.00	22.60
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1848.00	7.92	2.71	1.13	0.45	22.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2261.19	23.56	4.94	1.74	0.29	25.01
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2132.93	15.31	2.70	2.25	0.00	23.86
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1495.49	7.32	2.85	0.81	0.54	18.56
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1940.61	19.51	3.08	0.51	0.00	22.60
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1787.92	9.17	3.18	3.88	0.00	24.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1796.36	11.33	2.67	3.33	0.00	19.32
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1879.12	18.85	4.58	1.53	1.02	21.39
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1869.24	17.61	1.87	2.67	1.07	22.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1911.18	20.59	5.10	0.57	0.38	24.18
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2015.55	18.41	4.29	2.45	1.23	28.22
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1892.60	22.02	0.00	4.08	0.82	18.75
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2018.71	22.91	2.29	2.08	1.25	19.37
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2376.89	38.68	2.80	3.08	0.56	28.59
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1711.40	16.49	2.06	1.03	0.00	24.73
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1918.04	31.35	1.74	1.45	0.58	24.97
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2135.85	15.54	3.29	3.89	0.00	24.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1782.04	16.04	2.21	1.11	0.00	26.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1616.85	17.67	1.06	0.71	0.00	20.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1878.57	13.28	5.53	2.95	0.37	21.02
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1836.28	28.78	3.45	0.00	0.00	28.78
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1704.25	13.05	0.77	1.15	0.00	25.33
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1885.22	35.67	5.10	4.53	0.00	20.95
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1896.10	15.59	4.10	6.56	0.00	23.79
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1551.32	12.20	3.62	1.81	0.00	18.08
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1941.86	16.52	2.15	2.87	0.72	23.70
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1787.34	5.98	1.49	3.73	0.00	18.67
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1555.12	24.53	2.60	1.11	0.00	19.32
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1991.78	8.18	4.31	3.88	0.00	20.25
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1773.39	22.26	2.57	1.71	0.86	17.98
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1736.52	21.66	3.33	1.33	0.33	26.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1879.91	10.86	4.83	0.60	0.00	16.89
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1670.85	11.38	2.84	2.84	0.00	24.17
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1649.16	15.81	2.06	1.72	1.03	19.25
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1846.95	33.28	4.83	2.68	0.54	22.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1638.96	13.47	0.00	3.37	0.00	22.89
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1696.47	22.22	2.22	1.11	0.00	22.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2518.91	22.10	2.33	13.96	0.00	19.77
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1667.00	9.52	0.00	1.06	0.00	23.27
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1621.81	13.20	2.40	0.40	0.40	19.61
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1767.76	8.72	3.63	5.09	0.00	20.35
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1916.29	12.26	3.07	1.53	0.00	34.49
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1808.85	21.70	2.47	0.99	0.49	25.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1743.55	6.59	6.59	0.00	0.00	16.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1842.34	10.06	2.51	2.51	0.50	23.63
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1601.97	11.27	1.80	1.80	0.00	26.14
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1769.29	18.93	0.00	1.72	0.00	27.54
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1719.02	24.05	2.23	2.23	0.45	28.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1442.49	14.47	3.52	1.17	0.00	21.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1743.02	19.79	3.30	1.32	0.00	25.07
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1516.82	6.23	1.56	2.59	0.00	25.43
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1420.78	19.69	3.50	0.44	0.00	22.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1819.32	12.30	3.35	1.12	0.56	26.84
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1251.61	9.27	0.88	1.77	0.44	22.52
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1704.09	10.80	2.70	0.39	0.00	21.99
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1639.58	17.22	3.54	0.00	0.00	22.28
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1506.26	7.21	1.92	1.92	0.00	27.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1539.30	19.48	3.18	0.80	0.80	19.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1816.18	16.41	2.43	1.22	0.61	18.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1978.96	8.30	2.77	2.08	0.00	26.28
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1535.54	15.58	1.90	0.38	0.00	20.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1782.16	27.37	1.55	0.52	0.00	21.17
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	1945.78	11.49	0.60	1.21	0.00	27.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1398.17	13.94	3.17	1.90	0.63	25.35
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1819.97	6.40	5.33	1.07	1.60	34.65
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2195.24	9.19	2.30	1.72	0.57	35.05
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1704.17	23.65	3.09	2.06	0.51	32.91
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1706.84	9.90	4.95	3.54	0.00	28.29
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2146.23	17.02	1.13	1.70	0.00	28.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1438.20	18.72	3.74	0.42	0.42	20.39
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	1771.24	20.36	4.70	2.35	0.00	17.23
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1784.60	8.35	2.09	1.67	0.00	27.56
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1480.34	11.62	3.72	0.46	0.00	31.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1741.53	8.70	2.68	2.01	0.67	28.77
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	1810.83	13.37	1.60	2.67	0.00	21.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1545.26	23.44	1.21	0.81	0.00	25.46
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1807.07	11.01	5.51	0.00	0.00	28.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2112.52	12.45	2.67	0.00	0.89	25.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1159.68	5.70	5.70	3.99	0.00	27.35
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1786.88	12.27	5.37	0.77	0.00	26.84
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2129.61	9.85	1.09	1.09	0.00	23.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1430.33	14.70	1.78	1.34	0.45	18.71
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	1549.59	5.72	5.72	1.56	0.00	23.92
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2633.86	8.62	1.33	3.32	0.00	28.51
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1598.45	16.63	4.16	6.24	0.00	20.79
Macrophage - monocyte derived, donor1	11232-116C8	471.56	1.14	0.00	0.00	0.46	2.05
Macrophage - monocyte derived, donor2	11313-117C8	278.56	0.73	0.00	0.00	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	308.30	0.79	0.00	0.26	0.00	3.15
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	932.47	4.25	5.31	0.00	0.00	18.05
Mallassez-derived cells, donor2	11929-125I3	321.34	1.27	1.58	0.00	0.00	7.29
Mallassez-derived cells, donor3	11930-125I4	593.75	3.20	1.67	0.28	0.00	11.54
Mammary Epithelial Cell, donor1	11273-116H4	909.25	1.79	1.99	0.40	0.90	10.36
Mammary Epithelial Cell, donor2	11350-117G9	674.07	1.74	1.16	0.00	0.00	10.42
Mammary Epithelial Cell, donor3	11422-118F9	350.44	1.00	1.25	0.50	0.00	7.73
Mast cell - stimulated, donor1	11487-119E2	146.43	1.36	0.68	0.00	0.00	2.71
Mast cell, donor1	11563-120D6	602.89	1.08	0.32	0.22	0.22	3.03
Mast cell, donor2	11565-120D8	782.46	3.27	0.00	0.30	1.78	1.19
Mast cell, donor3	11566-120D9	989.65	4.95	0.23	0.68	1.58	1.35
Mast cell, donor4	11567-120E1	681.85	2.13	0.00	0.18	0.53	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	481.72	1.77	0.22	0.22	0.67	3.66
Mast cell, expanded and stimulated, donor8	11942-126A7	741.86	4.09	0.00	0.00	0.00	5.84
Mast cell, expanded, donor5	11939-126A4	654.26	3.79	0.23	0.23	0.46	2.06
Mast cell, expanded, donor8	11941-126A6	576.58	3.01	0.84	0.17	1.00	1.84
Melanocyte - dark, donor1	11502-119F8	776.48	1.19	0.50	0.50	0.20	7.56
Melanocyte - dark, donor2	11582-120F7	754.81	4.50	1.04	2.08	0.00	6.58
Melanocyte - dark, donor3	11663-122F7	350.54	0.43	0.00	0.00	0.00	8.69
Melanocyte - light, donor1	11274-116H5	175.60	0.71	0.00	0.00	0.00	1.88
Melanocyte - light, donor2	11351-117H1	233.40	0.00	0.00	0.00	0.00	2.73
Melanocyte - light, donor3	11423-118G1	253.23	0.00	0.00	0.87	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	567.90	2.50	0.00	0.94	0.10	8.54
Melanocyte, donor2 (MC+2)	12739-135I3	639.28	2.69	0.54	0.27	0.27	7.80
Melanocyte, donor3 (MC+3)	12837-137B2	374.73	2.14	0.00	0.27	0.27	3.21
Meningeal Cells, donor1	11493-119E8	574.02	0.62	0.37	0.25	0.00	8.93
Meningeal Cells, donor2	11573-120E7	663.74	0.44	0.44	0.00	0.00	13.64
Meningeal Cells, donor3	11654-122E7	618.43	0.82	0.57	0.16	0.33	10.68
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	949.57	2.57	0.29	0.00	0.29	13.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	577.53	2.11	0.30	0.20	0.91	4.93
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	373.22	0.00	0.00	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	639.69	2.62	0.00	0.00	0.00	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	433.43	5.02	0.00	0.00	0.00	17.22
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	482.20	1.27	0.21	0.21	0.21	2.12
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	526.27	1.51	0.50	1.01	0.00	5.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	580.37	1.10	0.22	0.66	0.22	9.23
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	715.98	2.92	0.73	0.73	0.00	13.15
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	601.94	1.02	0.61	1.43	0.00	10.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	1121.08	2.22	0.14	0.28	0.55	4.43
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	689.18	2.97	0.37	0.37	0.37	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1106.80	1.84	0.00	0.26	0.92	3.82
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1108.92	2.67	1.19	0.89	0.30	3.56
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	642.27	0.00	0.00	2.34	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1002.23	3.20	0.00	1.28	0.00	17.29
Mesenchymal stem cells - adipose, donor0	11217-116B2	874.41	2.13	0.35	0.71	0.00	13.82
Mesenchymal stem cells - hepatic, donor0	11218-116B3	1305.62	1.56	0.00	0.31	0.00	5.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	834.55	5.08	0.00	2.18	0.00	21.05
Mesothelial Cells, donor1	11247-116E5	379.20	0.80	0.80	0.00	0.00	5.57
Mesothelial Cells, donor2	12156-128G5	494.96	0.50	0.00	0.50	0.00	9.01
Mesothelial Cells, donor3	11402-118D7	270.56	0.87	0.36	0.14	0.14	4.19
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	97.22	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	386.65	1.72	0.49	0.25	0.25	3.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	337.45	0.88	0.00	0.00	0.29	3.53
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	62.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	410.37	1.86	0.62	0.93	0.31	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	329.82	1.24	0.21	0.41	0.00	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	57.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	406.43	1.50	0.25	0.25	0.00	2.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	266.72	0.47	0.00	0.00	0.00	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	410.29	2.03	0.41	0.41	0.61	2.85
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	298.56	1.19	0.00	0.79	0.40	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	410.61	2.65	0.00	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	455.54	1.14	0.00	0.38	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	55.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	424.66	2.76	0.00	0.21	0.21	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	119.71	0.00	0.00	0.92	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	272.42	1.79	0.00	0.00	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	68.74	1.68	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	462.41	2.76	0.00	0.75	0.00	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	257.87	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	78.51	0.00	0.00	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	297.48	4.37	0.23	0.23	0.00	2.53
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	274.28	0.00	0.42	0.21	0.00	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	266.40	1.22	0.00	0.41	0.00	2.24
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	376.09	1.29	0.21	0.00	0.00	2.57
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	194.50	1.11	0.22	0.22	0.22	2.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	250.12	0.88	0.00	0.22	0.00	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	108.49	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	74.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	144.05	1.36	0.27	1.09	0.00	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	203.51	0.59	0.00	0.59	0.00	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	55.61	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	366.18	3.36	0.00	0.96	0.00	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	270.96	0.80	0.00	0.40	0.00	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	408.47	0.50	0.00	0.00	0.00	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	431.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	356.91	1.31	0.44	0.44	0.00	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	48.56	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	48.03	0.64	0.00	0.00	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	306.92	1.24	0.00	0.00	0.00	2.73
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	78.64	0.70	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	55.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	169.57	1.37	0.00	0.34	0.00	3.42
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	73.96	0.00	0.00	0.00	0.44	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	71.02	0.00	0.00	0.00	0.00	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	281.11	0.84	0.28	0.00	0.00	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	120.95	0.83	0.00	0.00	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	45.45	0.00	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	151.44	1.81	0.30	0.30	0.00	2.41
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	178.64	1.67	0.42	0.00	0.00	5.01
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	114.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	161.63	0.00	0.57	0.00	0.00	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	135.83	0.28	0.14	0.14	0.14	2.35
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	179.07	0.00	0.52	0.52	0.00	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	123.12	0.43	0.43	0.00	0.00	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	34.94	0.00	0.00	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	107.29	0.00	0.00	0.27	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	193.37	1.50	0.60	0.60	0.00	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	124.44	0.00	0.14	0.14	0.00	2.26
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	211.81	1.91	0.00	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	183.32	0.66	0.22	0.22	0.00	3.32
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	64.84	0.00	0.00	0.00	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	191.20	1.70	0.00	0.00	0.28	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	229.09	1.23	0.49	0.25	0.00	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	69.08	0.00	0.00	0.65	0.65	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	140.25	0.88	0.29	0.29	0.00	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	222.30	2.02	0.29	0.29	0.29	3.75
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	203.19	1.65	0.00	0.00	0.00	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	141.74	1.19	0.00	0.30	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	662.97	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	600.62	7.13	1.78	1.78	1.78	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	379.17	1.31	0.33	0.99	0.66	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	417.62	4.21	0.00	1.05	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	606.50	1.38	0.00	0.99	1.78	2.57
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	422.82	2.79	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	442.37	3.38	0.00	1.13	0.38	6.01
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	384.60	1.86	0.00	0.27	0.00	2.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	529.43	1.47	0.00	0.11	0.00	2.49
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	431.72	2.95	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	309.63	1.47	0.00	1.10	0.37	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	287.79	4.67	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	989.24	2.67	0.00	0.00	0.00	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	525.49	0.00	0.00	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	348.43	2.02	0.00	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	352.91	2.95	0.42	0.84	0.42	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1586.66	5.45	0.00	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1273.50	3.81	0.64	0.64	0.00	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1562.98	5.67	0.00	0.00	0.00	7.29
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	613.24	4.53	0.00	3.02	1.51	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	576.73	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	815.61	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	346.93	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	389.02	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	528.90	1.72	0.86	0.00	0.65	10.13
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	689.33	2.09	0.00	0.00	0.52	6.79
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	203.58	0.67	0.67	1.33	0.00	6.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	118.12	0.00	0.42	0.83	0.00	3.76
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	484.10	1.90	0.76	0.95	0.19	19.58
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	180.33	0.00	0.00	1.60	0.00	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	125.79	0.68	0.00	0.00	0.68	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	727.71	1.84	0.00	3.68	0.00	23.89
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	217.64	0.84	0.42	0.42	0.42	7.12
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	321.46	0.93	0.46	0.46	0.00	18.13
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	275.63	0.27	0.00	0.81	0.00	4.05
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	258.59	1.47	0.42	0.84	0.00	4.20
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	679.22	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	364.33	0.50	0.00	0.50	0.50	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	422.52	2.44	0.00	1.62	0.00	8.39
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	357.93	1.59	0.45	0.91	1.36	3.85
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	293.13	0.82	0.00	0.49	0.00	3.59
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	405.88	4.01	0.36	0.18	0.00	4.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	360.17	0.53	0.00	0.53	1.06	3.18
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	240.12	0.00	0.00	1.20	0.00	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	811.25	4.27	0.33	0.98	0.00	11.49
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	260.04	0.49	0.00	0.33	0.00	5.04
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	327.19	1.76	0.00	0.35	0.35	3.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	361.46	1.41	0.00	2.81	0.00	8.44
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	354.44	0.92	0.00	0.46	0.00	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	352.52	2.25	0.32	0.96	0.00	7.39
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	806.00	6.21	0.00	2.76	0.34	12.42
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	907.71	0.00	0.00	5.06	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	265.34	1.11	0.00	0.45	0.22	4.68
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	337.44	2.54	0.00	0.42	0.00	7.20
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	429.13	0.95	0.00	0.47	0.00	4.27
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	404.78	1.29	0.00	0.86	0.43	6.44
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1002.08	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	368.54	0.33	0.00	0.67	0.00	4.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	177.19	0.00	0.00	0.45	0.00	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	361.48	1.19	0.40	1.19	0.00	7.54
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	363.10	1.86	0.00	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	584.21	3.41	0.00	1.14	0.00	4.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	271.14	0.00	0.33	0.65	0.00	3.26
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	227.04	0.00	0.00	1.31	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	295.80	0.00	0.00	0.45	0.45	4.52
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	289.27	0.00	1.76	2.65	0.88	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	354.36	1.99	0.00	2.66	1.33	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	383.94	0.99	0.00	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	218.59	0.00	0.77	0.00	0.00	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	538.05	1.81	0.30	4.84	0.00	3.63
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	279.15	1.55	0.00	0.22	0.00	5.53
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	312.40	2.71	0.00	1.36	0.68	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	945.26	30.66	0.00	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	408.49	1.22	0.61	1.83	0.00	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	220.00	0.31	0.31	0.31	0.00	5.35
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	299.02	0.91	0.00	0.91	0.00	3.03
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	363.92	1.58	0.00	1.58	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	663.18	7.94	1.13	5.67	0.00	9.07
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1360.57	10.12	0.00	5.06	0.00	15.17
Myoblast, donor1	11241-116D8	536.79	3.35	0.12	0.50	0.00	9.94
Myoblast, donor2	11322-117D8	616.60	4.41	0.77	0.96	0.38	5.56
Myoblast, donor3	11398-118D3	419.90	0.84	0.84	0.84	0.17	6.89
NK T cell leukemia cell line:KHYG-1	10777-110G3	3598.41	8.32	1.46	3.65	2.19	24.52
Natural Killer Cells, donor1	11230-116C6	2505.03	4.00	2.77	0.62	0.62	5.84
Natural Killer Cells, donor2	11311-117C6	2147.08	8.44	2.71	1.81	1.81	3.32
Natural Killer Cells, donor3	11387-118C1	2018.70	7.55	2.58	2.58	0.37	4.23
Neural stem cells, donor1	11275-116H6	372.01	0.36	1.45	0.00	0.36	7.62
Neural stem cells, donor2	11352-117H2	296.55	0.00	0.00	0.00	0.00	7.70
Neurons, donor1	11494-119E9	1027.52	6.83	3.41	2.28	1.14	13.65
Neurons, donor2	11574-120E8	735.79	1.32	1.32	0.00	0.22	12.99
Neurons, donor3	11655-122E8	1164.19	6.58	3.29	3.29	2.47	17.27
Neutrophils, donor1	11233-116C9	292.32	1.86	0.00	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	269.60	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	273.66	2.44	0.00	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	960.45	2.97	0.36	0.59	0.47	2.61
Nucleus Pulposus Cell, donor2	11409-118E5	783.08	1.63	0.33	1.63	0.33	3.58
Nucleus Pulposus Cell, donor3	11462-119B4	1104.84	4.61	0.00	0.00	0.00	11.83
Olfactory epithelial cells, donor1	11933-125I7	649.99	2.34	0.28	0.83	0.14	4.27
Olfactory epithelial cells, donor2	11934-125I8	734.44	8.40	0.58	1.30	0.87	9.41
Olfactory epithelial cells, donor3	11935-125I9	700.78	1.25	0.00	0.68	0.34	3.06
Olfactory epithelial cells, donor4	11936-126A1	645.55	1.46	0.10	0.10	0.29	4.68
Oligodendrocyte - precursors, donor1	11496-119F2	572.33	0.00	0.00	0.00	0.60	11.43
Osteoblast - differentiated, donor1	11276-116H7	659.56	0.85	0.21	0.00	0.85	2.34
Osteoblast - differentiated, donor2	11353-117H3	687.01	5.72	0.00	3.43	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	702.02	4.34	0.00	1.86	0.00	3.10
Osteoblast, donor1	11277-116H8	472.37	0.59	0.20	0.20	0.39	17.20
Osteoblast, donor2	11354-117H4	503.56	0.70	0.00	0.00	0.00	11.24
Osteoblast, donor3	11426-118G4	502.27	0.36	0.00	1.78	0.00	9.42
Pancreatic stromal cells, donor1	11249-116E7	651.22	3.45	0.17	0.42	0.34	7.50
Pericytes, donor1	11491-119E6	824.59	1.45	0.11	0.45	0.33	2.00
Pericytes, donor2	11571-120E5	1163.29	2.49	0.23	0.45	0.00	7.02
Pericytes, donor3	11652-122E5	1009.93	3.26	0.41	0.61	0.20	11.39
Perineurial Cells, donor1	11499-119F5	654.51	0.57	0.23	0.00	0.00	7.01
Perineurial Cells, donor2	11579-120F4	684.65	1.10	0.46	0.09	0.00	7.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2264.96	1.91	2.23	0.00	0.96	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1694.45	11.75	1.22	1.71	0.73	3.67
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1445.19	3.36	0.26	1.42	0.26	2.85
Placental Epithelial Cells, donor1	11278-116H9	877.50	3.35	2.39	1.20	0.48	12.91
Placental Epithelial Cells, donor2	11355-117H5	420.27	2.22	3.33	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	637.08	1.96	1.57	0.39	0.00	5.89
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	561.39	4.75	0.00	1.27	0.00	5.38
Preadipocyte - breast, donor1	11467-119B9	539.69	2.06	1.13	0.00	0.00	3.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	85.36	0.13	0.13	0.00	0.00	4.44
Preadipocyte - breast, donor2	11328-117E5	600.02	4.05	0.23	0.68	0.00	4.28
Preadipocyte - omental, donor1	11468-119C1	477.92	1.39	0.64	0.00	0.85	4.05
Preadipocyte - omental, donor2	11329-117E6	374.93	1.75	0.00	0.44	0.44	5.24
Preadipocyte - omental, donor3	11403-118D8	442.07	1.29	0.72	0.29	0.14	9.88
Preadipocyte - perirenal, donor1	11469-119C2	747.06	3.94	0.98	0.00	0.00	7.87
Preadipocyte - subcutaneous, donor1	11279-116I1	235.25	0.61	0.00	0.00	0.00	7.06
Preadipocyte - subcutaneous, donor2	11356-117H6	539.55	3.01	0.89	0.71	0.18	16.11
Preadipocyte - subcutaneous, donor3	11428-118G6	696.63	2.21	0.34	1.70	0.17	12.43
Preadipocyte - visceral, donor1	11280-116I2	553.48	1.30	0.28	0.19	0.75	12.39
Preadipocyte - visceral, donor2	11357-117H7	428.43	1.38	1.38	1.38	0.00	10.58
Preadipocyte - visceral, donor3	11429-118G7	692.04	3.24	0.31	0.52	0.00	13.69
Prostate Epithelial Cells (polarized), donor1	11253-116F2	758.33	5.73	0.60	0.30	0.91	6.03
Prostate Epithelial Cells, donor2	11331-117E8	301.57	2.71	1.08	0.27	0.00	6.64
Prostate Epithelial Cells, donor3	11404-118D9	667.12	2.63	0.18	0.86	0.37	3.98
Prostate Stromal Cells, donor1	11254-116F3	682.95	3.76	0.57	0.57	0.11	9.34
Prostate Stromal Cells, donor2	11332-117E9	651.21	4.84	0.54	0.72	0.00	12.55
Prostate Stromal Cells, donor3	11405-118E1	676.96	4.48	0.00	1.46	0.00	8.34
Renal Cortical Epithelial Cells, donor1	11516-119H4	591.64	0.73	0.36	0.00	0.36	4.74
Renal Cortical Epithelial Cells, donor2	11596-120H3	527.88	0.83	0.14	0.14	0.14	4.85
Renal Epithelial Cells, donor1	11517-119H5	387.02	0.00	0.51	0.00	0.00	3.04
Renal Epithelial Cells, donor2	11597-120H4	627.38	2.13	0.71	0.71	0.00	9.96
Renal Epithelial Cells, donor3	11678-122H4	463.37	0.95	0.21	0.21	0.00	5.82
Renal Glomerular Endothelial Cells, donor1	11514-119H2	742.81	2.72	0.68	0.00	0.00	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	845.24	2.02	0.13	0.27	0.00	13.48
Renal Glomerular Endothelial Cells, donor3	11675-122H1	446.02	3.77	1.11	0.67	0.22	16.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	336.71	1.33	0.00	0.00	0.00	2.66
Renal Mesangial Cells, donor1	11518-119H6	591.16	0.22	1.32	0.00	0.44	6.38
Renal Mesangial Cells, donor2	11598-120H5	793.14	1.88	1.25	0.63	0.00	8.78
Renal Mesangial Cells, donor3	11679-122H5	597.82	1.66	1.11	0.00	0.00	4.44
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	653.88	0.81	0.54	0.00	0.81	8.05
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	682.30	3.37	0.00	0.84	0.00	10.96
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	670.91	2.70	0.58	0.77	0.19	14.46
Retinal Pigment Epithelial Cells, donor0	11215-116A9	853.56	2.59	0.52	0.26	0.26	12.70
Retinal Pigment Epithelial Cells, donor1	11528-119I7	852.73	2.27	1.42	0.57	1.14	11.37
Retinal Pigment Epithelial Cells, donor2	11608-120I6	642.17	1.03	1.03	1.03	0.00	10.29
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1167.72	1.76	0.50	0.00	0.25	8.53
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	758.78	1.60	1.20	0.13	0.67	3.21
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	715.62	5.36	0.00	1.79	0.89	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1069.37	0.55	0.00	0.00	0.00	13.21
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	510.45	0.58	0.00	0.58	0.00	7.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	517.50	1.56	0.26	0.00	0.13	12.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	472.30	1.79	0.50	0.30	0.40	10.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	592.27	1.00	0.78	0.45	0.45	14.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	808.39	4.34	0.12	0.12	0.12	14.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	573.28	1.75	0.35	0.35	0.58	9.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	377.90	1.39	0.46	0.69	0.69	17.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	490.68	1.64	0.14	0.14	0.00	11.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	373.49	3.48	0.15	0.30	0.00	12.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	580.04	1.43	0.18	0.90	0.00	11.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	642.11	1.58	0.57	0.86	0.00	12.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	531.10	1.72	0.75	0.21	0.00	13.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	662.04	2.88	0.44	0.22	0.22	20.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	475.46	2.10	0.57	0.38	0.00	13.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	439.73	1.12	0.09	0.28	0.28	11.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	497.01	0.75	0.19	0.00	0.19	10.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	448.81	1.33	0.40	0.53	0.13	10.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	432.39	2.14	0.19	0.29	0.00	11.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	617.94	0.95	0.38	0.76	0.19	15.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	506.41	1.07	0.21	0.00	0.00	12.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	329.92	3.92	0.00	1.12	1.40	13.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	469.63	1.88	0.17	0.68	0.17	12.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	523.65	1.09	0.00	0.00	0.18	14.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	450.06	1.47	0.25	0.37	0.12	11.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	591.81	1.21	0.40	0.54	0.00	16.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	704.79	1.42	0.47	0.00	0.00	13.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	500.80	1.19	0.60	0.60	0.00	13.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	401.51	3.04	0.00	1.17	0.47	15.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	633.06	1.45	0.62	1.04	0.00	10.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	411.23	7.08	0.44	0.22	0.44	13.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	482.94	1.25	1.25	0.00	0.21	15.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	612.09	1.08	0.54	0.67	0.13	16.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	364.60	0.68	1.02	0.51	0.34	12.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	462.71	1.54	0.39	0.39	0.19	16.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	599.55	1.89	0.00	0.34	0.00	13.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	391.34	0.96	0.27	0.55	0.27	10.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	536.01	6.07	0.49	0.82	0.49	16.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	504.13	1.87	0.34	0.34	0.17	12.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	498.02	0.89	0.59	0.15	0.00	11.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	394.23	0.53	0.80	0.80	0.27	13.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	658.70	1.66	0.00	0.28	0.14	9.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	664.30	1.90	0.24	0.24	0.00	8.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	487.73	0.40	0.20	0.00	0.00	9.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	732.96	2.54	0.19	0.38	0.09	6.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	504.83	4.54	0.35	0.00	0.35	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	565.44	1.51	0.00	0.91	0.30	8.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	833.82	2.94	0.00	0.49	0.12	10.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	702.29	1.75	0.00	0.29	0.15	13.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	544.54	3.65	0.00	0.00	0.00	12.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	869.54	2.11	0.00	0.30	0.00	10.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	553.26	1.13	0.23	0.45	0.45	9.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	589.50	0.60	0.30	0.30	0.00	7.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	692.27	2.95	0.24	0.00	0.00	10.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	598.29	5.12	0.64	0.21	0.00	10.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	632.23	2.40	0.60	1.20	1.20	4.21
Schwann Cells, donor1	11498-119F4	1017.84	2.63	0.00	0.75	0.19	11.85
Schwann Cells, donor2	11578-120F3	534.18	3.40	0.00	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	474.31	1.75	0.22	0.22	0.22	8.54
Sebocyte, donor1	11220-116B5	345.09	0.00	0.55	0.00	0.00	7.12
Sebocyte, donor2	11301-117B5	562.04	2.30	0.92	0.00	0.00	5.06
Sebocyte, donor3	11378-118B1	552.38	0.62	0.00	1.03	0.00	3.71
Sertoli Cells, donor1	11255-116F4	677.55	1.66	0.00	0.00	0.00	6.63
Sertoli Cells, donor2	11333-117F1	926.39	0.00	0.00	0.00	0.00	8.47
Skeletal Muscle Cells, donor1	11281-116I3	852.68	2.55	0.35	0.44	0.79	9.94
Skeletal Muscle Cells, donor2	11358-117H8	474.91	2.89	0.72	2.17	0.00	3.61
Skeletal Muscle Cells, donor3	11430-118G8	423.04	3.34	0.84	0.84	0.00	12.54
Skeletal Muscle Cells, donor4	11451-119A2	888.99	6.76	0.16	0.79	0.00	18.69
Skeletal Muscle Cells, donor5	11455-119A6	934.68	3.57	0.15	1.04	0.00	15.61
Skeletal Muscle Cells, donor6	11459-119B1	913.10	6.16	0.00	0.77	0.15	20.47
Skeletal Muscle Satellite Cells, donor1	11240-116D7	1041.57	3.40	0.25	0.76	0.63	7.94
Skeletal Muscle Satellite Cells, donor2	11321-117D7	804.91	3.42	0.29	1.00	0.00	7.13
Skeletal Muscle Satellite Cells, donor3	11397-118D2	585.83	2.18	0.30	0.79	0.10	15.28
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	786.74	1.10	0.34	0.25	0.34	8.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	487.82	1.45	0.00	1.45	0.00	10.86
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	695.98	5.23	0.14	0.69	0.00	6.47
Skin - palm, donor1	10286-104F7	459.32	2.69	0.00	0.00	0.00	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	549.52	1.73	1.30	1.01	0.00	8.07
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	183.21	0.00	1.64	0.00	0.00	12.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	488.02	2.21	0.78	0.26	0.13	6.62
Small Airway Epithelial Cells, donor1	11256-116F5	725.76	4.03	2.09	0.42	0.28	7.78
Small Airway Epithelial Cells, donor2	11334-117F2	396.51	2.25	0.70	0.00	0.00	7.45
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	196.64	0.42	0.00	0.42	0.85	11.42
Small Airway Epithelial Cells, donor3	11406-118E2	384.87	0.90	0.45	0.52	0.00	3.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1339.56	10.18	0.62	1.23	0.00	7.10
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	224.78	1.11	0.00	0.00	0.00	5.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	483.78	2.94	0.59	0.00	0.00	9.99
Smooth Muscle Cells - Aortic, donor1	11283-116I5	315.58	0.44	0.00	0.44	0.88	5.97
Smooth Muscle Cells - Aortic, donor2	11360-117I1	343.77	0.39	0.00	0.79	0.39	10.24
Smooth Muscle Cells - Aortic, donor3	11432-118H1	423.37	0.77	0.00	0.00	0.00	8.50
Smooth Muscle Cells - Bladder, donor1	11519-119H7	787.60	4.00	0.00	2.00	2.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	356.38	0.40	0.67	0.27	0.40	5.32
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	765.59	3.32	0.00	1.33	0.44	10.42
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	695.08	4.48	0.51	0.38	0.00	13.96
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	783.04	2.28	0.65	0.33	0.00	8.79
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	556.98	1.48	1.18	1.48	0.89	6.79
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	574.30	1.14	0.14	1.00	0.14	7.69
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	665.99	1.14	0.00	0.49	0.00	4.88
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	496.83	2.44	0.00	0.91	0.00	5.18
Smooth Muscle Cells - Carotid, donor1	11285-116I7	462.19	1.01	0.25	0.25	0.00	6.31
Smooth Muscle Cells - Carotid, donor2	11362-117I3	153.02	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	404.36	5.25	0.95	0.00	0.00	10.01
Smooth Muscle Cells - Colonic, donor1	11239-116D6	824.97	3.24	0.44	0.44	0.00	7.52
Smooth Muscle Cells - Colonic, donor2	11320-117D6	660.14	4.09	0.22	0.86	0.00	7.32
Smooth Muscle Cells - Colonic, donor3	11396-118D1	631.22	3.78	0.42	1.68	0.21	10.60
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	306.26	0.93	0.31	0.62	0.31	7.12
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	490.43	4.31	1.08	0.00	0.00	7.55
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	548.70	2.39	0.00	1.20	0.00	11.36
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	685.53	2.39	0.68	0.00	0.00	8.88
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1063.99	1.57	0.39	0.24	0.31	4.48
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	312.39	2.01	0.30	0.10	1.81	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	518.37	1.37	0.00	0.91	0.00	6.83
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	608.64	4.23	1.21	0.00	0.00	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	708.94	1.06	0.53	1.06	1.06	22.52
Smooth Muscle Cells - Prostate, donor1	11257-116F6	663.27	2.66	0.13	0.53	0.13	8.66
Smooth Muscle Cells - Prostate, donor2	11335-117F3	631.36	3.51	0.38	0.25	0.25	7.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	738.67	3.80	0.00	0.51	0.00	3.80
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	517.00	1.21	0.30	0.15	0.30	11.46
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	521.37	0.75	0.75	0.75	0.00	5.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	368.28	5.17	0.00	0.00	0.00	10.34
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	378.57	0.00	0.47	0.00	0.00	8.37
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	445.81	3.53	0.50	1.51	0.00	8.08
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	411.49	4.07	0.63	0.94	0.00	7.83
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	506.51	1.77	0.00	0.59	0.29	5.01
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	542.99	0.67	0.50	0.42	0.17	12.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	729.70	2.34	0.47	0.00	0.00	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	457.52	0.43	1.30	0.43	0.00	9.07
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	624.90	1.78	0.51	1.27	0.00	8.92
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	659.43	2.26	0.19	0.38	0.00	12.97
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	729.88	1.54	0.28	0.14	0.00	15.51
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	961.72	1.59	0.25	0.08	0.00	8.88
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	458.09	0.48	0.48	0.00	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	475.87	1.22	0.24	0.00	0.00	8.56
Smooth Muscle Cells - Uterine, donor1	11258-116F7	697.53	2.43	0.22	0.44	0.88	10.83
Smooth Muscle Cells - Uterine, donor3	11466-119B8	806.64	4.68	0.00	0.59	0.59	10.24
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	554.51	2.33	0.00	0.39	0.00	5.05
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	420.74	5.29	0.00	0.26	0.00	6.61
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1087.94	8.18	0.37	0.74	0.00	8.18
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	629.92	4.67	0.36	0.00	0.36	6.47
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	334.43	1.70	0.28	0.57	0.00	3.97
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	626.64	3.15	0.39	0.79	0.79	13.39
Smooth muscle cells - airway, control, donor1	11966-126D4	709.29	9.90	0.76	0.76	0.00	5.08
Smooth muscle cells - airway, control, donor2	11967-126D5	670.86	3.99	0.00	2.00	0.00	3.59
Smooth muscle cells - airway, control, donor3	11968-126D6	907.91	10.45	0.00	2.09	0.00	8.36
Smooth muscle cells - airway, control, donor4	11969-126D7	924.97	3.21	0.92	0.92	0.00	8.25
Synoviocyte, donor1	11291-117A4	565.39	1.35	0.17	0.00	2.02	7.24
Synoviocyte, donor2	11368-117I9	765.88	3.86	0.17	0.50	0.67	4.19
Synoviocyte, donor3	11440-118H9	1125.09	5.36	0.00	0.67	0.00	4.02
Trabecular Meshwork Cells, donor1	11532-120A2	617.83	1.79	0.00	0.36	1.07	9.65
Trabecular Meshwork Cells, donor2	11612-122A1	610.47	0.00	0.00	0.00	0.00	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	497.13	1.39	0.00	0.46	0.00	7.18
Tracheal Epithelial Cells, donor1	11292-117A5	566.16	0.29	0.79	0.14	0.36	6.59
Tracheal Epithelial Cells, donor2	11369-118A1	327.42	1.55	0.39	0.77	0.00	10.82
Tracheal Epithelial Cells, donor3	11441-118I1	410.03	1.72	0.00	1.15	0.00	10.31
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	780.83	2.83	0.49	0.86	0.37	1.11
Urethra, donor2	10319-105A4	525.14	3.60	1.80	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	618.19	1.06	1.06	0.53	0.27	2.66
Urothelial Cells, donor2	11600-120H7	766.68	1.20	0.00	0.80	0.00	3.20
Urothelial Cells, donor3	11681-122H7	634.21	0.92	0.46	0.92	0.00	2.06
Urothelial cells, donor0	11216-116B1	800.19	0.67	1.11	0.22	0.00	3.12
Whole blood (ribopure), donor090309, donation1	12179-129A1	2689.81	6.23	1.78	0.00	0.00	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	3478.24	11.44	0.00	1.43	0.00	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	1898.17	16.43	0.00	0.00	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	1973.40	7.23	1.03	0.34	2.75	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	2246.25	4.65	0.58	0.58	3.49	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	2317.80	9.37	0.00	0.00	0.00	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	2800.18	9.18	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	2034.85	11.87	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	1226.46	4.19	2.22	2.34	1.23	15.17
Wilms' tumor cell line:HFWT	10597-108E3	549.15	0.88	0.88	1.76	0.00	9.68
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	877.34	1.68	0.28	0.84	0.00	14.52
achilles tendon, donor2	10292-104G4	570.36	4.13	0.00	0.00	0.00	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1779.08	4.84	1.27	2.29	8.67	50.48
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1516.56	2.55	1.16	1.16	0.70	26.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1152.89	1.90	1.42	0.12	0.59	7.60
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1043.83	2.45	1.63	1.36	2.72	39.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2491.53	9.56	3.09	4.78	0.56	45.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1695.23	1.90	3.17	0.00	0.21	10.57
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1976.80	8.98	3.27	4.36	0.82	5.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	2587.87	7.05	2.20	2.20	0.00	11.02
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1670.19	4.90	1.23	1.23	0.41	7.35
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	3238.79	7.38	0.78	3.88	0.78	22.13
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	546.30	2.02	0.18	1.10	0.37	8.28
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1181.86	3.90	0.00	0.00	0.00	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1829.54	7.67	2.56	4.65	1.16	31.14
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2248.04	9.32	0.26	3.88	0.26	38.06
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1768.08	6.43	0.29	3.80	1.17	29.22
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	964.38	1.86	0.93	2.32	0.93	17.20
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	980.84	4.52	0.41	3.29	1.23	8.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	545.45	1.84	0.31	0.61	0.00	13.51
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1842.53	3.41	0.85	0.43	0.43	16.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1819.15	3.34	0.30	0.30	0.30	10.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1900.61	3.37	1.44	0.48	0.00	16.37
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1173.39	4.23	0.00	2.00	0.00	30.96
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	513.33	1.67	1.67	0.67	0.00	12.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	780.45	1.86	0.00	1.86	0.00	13.01
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1530.75	3.01	1.13	3.01	0.38	24.11
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	748.84	0.44	1.74	0.44	0.00	11.34
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	612.95	3.75	1.87	0.00	0.00	7.50
adenocarcinoma cell line:IM95m	10796-110I4	1401.93	1.88	0.94	3.06	0.24	8.48
adipose tissue, adult, pool1	10010-101C1	840.28	1.09	0.00	0.47	0.00	0.78
adipose, donor1	10184-103D4	2520.97	51.60	1.76	3.52	0.00	24.04
adipose, donor2	10185-103D5	738.04	4.06	2.84	2.03	1.22	2.84
adipose, donor3	10186-103D6	740.90	7.62	1.91	1.63	0.27	19.88
adipose, donor4	10187-103D7	770.54	7.80	0.00	0.00	0.00	37.27
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	926.72	1.10	0.16	1.26	0.95	21.78
adrenal gland, adult, pool1	10081-102A9	512.91	0.00	0.00	0.00	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	1058.31	2.13	0.00	0.13	0.27	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1605.35	3.22	2.14	1.43	0.36	15.01
amniotic membrane cells, donor1	12235-129G3	541.14	0.93	0.00	0.00	0.00	2.55
amniotic membrane cells, donor2	12236-129G4	877.04	3.72	0.34	1.01	0.34	7.78
amniotic membrane cells, donor3	12237-129G5	1105.34	2.95	0.59	1.18	0.00	3.24
amygdala - adult, donor10196	10167-103B5	259.69	0.00	2.37	0.00	1.19	4.74
amygdala, adult, donor10252	10151-102I7	360.11	1.22	1.22	0.41	0.41	3.65
amygdala, newborn, donor10223	10360-105E9	347.94	0.65	0.65	0.32	0.00	4.84
anaplastic carcinoma cell line:8305C	10428-106D5	1001.07	2.55	0.13	0.13	0.25	2.16
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1873.97	4.85	0.66	3.97	0.66	49.64
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1132.39	2.67	3.34	1.00	1.00	8.68
aorta, adult, pool1	10052-101G7	944.38	1.96	0.20	1.37	0.39	0.98
appendix, adult	10189-103D9	600.42	5.05	0.78	1.16	2.33	3.88
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1551.49	2.75	1.38	1.38	0.00	12.38
artery, adult	10190-103E1	1334.23	12.23	1.36	4.08	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	627.56	1.30	0.72	0.00	0.14	5.07
b cell line:RPMI1788	10427-106D4	1020.98	1.19	0.74	0.30	0.59	5.20
basal cell carcinoma cell line:TE 354.T	10702-109G9	496.63	1.66	1.11	0.28	0.55	4.99
bile duct carcinoma cell line:HuCCT1	10432-106D9	808.74	1.79	0.99	0.20	0.20	8.93
bile duct carcinoma cell line:TFK-1	10496-107C1	909.87	1.67	0.33	0.50	0.84	5.86
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2411.99	5.03	0.00	2.24	1.12	9.51
bladder, adult, pool1	10011-101C2	889.12	2.93	0.22	0.65	1.20	1.96
blood, adult, pool1	10053-101G8	2879.01	11.07	0.00	4.43	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	341.68	0.86	0.00	0.86	0.00	2.57
bone marrow, adult	10192-103E3	633.66	7.42	0.00	1.35	1.35	8.10
brain, adult, donor1	10084-102B3	386.45	0.00	0.00	3.08	0.00	4.10
brain, adult, pool1	10012-101C3	395.88	0.56	0.56	0.11	0.45	3.12
brain, fetal, pool1	10085-102B4	1437.21	0.00	2.67	5.34	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	2071.72	5.62	0.66	3.96	1.32	17.84
breast carcinoma cell line:MDA-MB-453	10419-106C5	944.66	0.87	1.37	0.12	0.62	3.50
breast, adult, donor1	10080-102A8	765.84	1.89	0.63	1.26	0.00	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1457.00	4.07	6.22	3.18	0.25	15.12
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1710.61	3.40	2.16	2.78	0.31	20.72
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2133.67	6.91	1.15	2.99	1.15	8.29
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	490.95	1.21	1.69	0.73	0.24	7.50
carcinoid cell line:NCI-H1770	10703-109H1	926.70	4.23	0.00	2.35	0.94	5.17
carcinoid cell line:NCI-H727	10735-110B6	550.29	1.09	0.22	0.44	0.11	11.16
carcinoid cell line:SK-PN-DW	10719-109I8	1544.87	7.29	0.32	1.58	0.32	20.60
carcinosarcoma cell line:JHUCS-1	10642-109A3	1616.23	5.86	0.27	2.13	0.53	5.86
caudate nucleus - adult, donor10196	10177-103C6	267.11	2.30	0.00	1.15	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	315.41	1.17	1.34	0.33	0.17	2.84
caudate nucleus, adult, donor10258	10379-105H1	433.27	0.76	2.29	0.00	1.53	3.82
caudate nucleus, newborn, donor10223	10354-105E3	555.94	2.20	0.37	0.00	0.00	5.86
cerebellum - adult, donor10196	10173-103C2	352.51	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	290.37	1.07	0.43	0.00	0.21	1.71
cerebellum, adult, pool1	10083-102B2	586.06	2.76	0.34	1.72	0.00	3.79
cerebellum, newborn, donor10223	10357-105E6	848.55	0.83	0.83	1.66	0.00	3.32
cerebral meninges, adult	10188-103D8	483.10	2.02	1.01	0.50	0.00	4.29
cerebrospinal fluid, donor2	10294-104G6	495.54	2.92	0.00	1.46	0.73	5.85
cervical cancer cell line:D98-AH2	10552-107I3	996.70	0.72	0.43	0.00	0.72	3.31
cervical cancer cell line:ME-180	10553-107I4	642.81	0.50	0.83	0.33	0.83	7.13
cervix, adult, pool1	10013-101C4	1214.42	3.88	0.21	0.63	1.78	2.41
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	910.02	2.23	0.00	0.28	0.84	7.38
chondrosarcoma cell line:SW 1353	10700-109G7	195.94	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1448.93	7.08	0.37	0.12	0.25	9.69
choriocarcinoma cell line:SCH	10785-110H2	1393.78	3.82	3.33	1.72	0.25	10.47
choriocarcinoma cell line:T3M-3	10618-108G6	516.57	0.71	0.71	1.19	0.24	2.13
chorionic membrane cells, donor1	12238-129G6	580.67	2.85	0.00	0.28	0.00	3.13
chorionic membrane cells, donor2	12239-129G7	402.99	2.29	0.20	0.30	0.20	5.67
chorionic membrane cells, donor3	12240-129G8	1016.55	11.54	1.10	0.00	0.00	7.14
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2137.75	23.23	10.10	3.03	0.00	32.31
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3136.39	7.11	1.15	5.76	1.34	39.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1497.52	1.69	0.42	1.27	1.27	23.44
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	537.74	1.54	0.26	0.51	0.77	8.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	557.53	0.97	0.73	0.73	0.24	7.01
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	485.61	0.61	0.20	0.20	0.00	6.72
chronic myelogenous leukemia cell line:K562	10454-106G4	985.25	2.36	0.88	1.47	2.94	12.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	1690.68	1.04	2.35	0.26	0.78	18.77
clear cell carcinoma cell line:JHOC-5	10638-108I8	1318.00	14.63	0.69	0.91	0.00	13.71
clear cell carcinoma cell line:TEN	10636-108I6	1444.44	6.07	1.56	0.69	1.39	6.77
colon carcinoma cell line:CACO-2	10513-107D9	619.96	0.92	1.83	0.55	0.37	11.53
colon carcinoma cell line:COLO-320	10420-106C6	1180.53	1.90	0.00	0.38	0.00	6.84
colon, adult, donor1	10082-102B1	913.94	0.00	1.19	3.57	1.19	3.57
colon, adult, pool1	10014-101C5	870.47	2.12	1.06	0.71	0.94	1.88
colon, fetal, donor1	10070-101I7	941.20	2.47	0.62	0.62	0.00	4.33
common myeloid progenitor CMP, donor1	12130-128D6	568.36	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	8537.51	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	997.74	0.00	0.42	0.42	2.97	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	839.78	1.96	1.06	0.30	0.60	10.11
cord blood derived cell line:COBL-a untreated	10449-106F8	950.13	1.83	0.71	0.99	1.13	11.56
corpus callosum, adult, pool1	10042-101F6	555.13	0.22	0.22	0.44	0.44	2.99
cruciate ligament, donor2	10295-104G7	598.13	2.43	0.81	1.62	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	998.39	3.21	0.80	1.61	0.00	4.82
diencephalon, adult	10193-103E4	403.42	3.36	1.92	0.48	0.00	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1937.69	16.30	1.15	1.38	0.23	21.35
ductal cell carcinoma cell line:KLM-1	10438-106E6	1370.93	2.82	1.80	0.26	0.00	13.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	605.42	1.69	1.20	0.24	0.24	9.15
ductus deferens, adult	10196-103E7	635.38	5.48	0.00	1.50	0.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	1434.47	2.88	1.44	4.32	1.44	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	1174.83	13.24	0.74	2.21	0.00	7.36
dura mater, adult, donor1	10041-101F5	704.39	0.99	0.33	0.00	0.25	1.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	731.95	3.33	3.78	0.67	0.89	25.32
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	853.60	2.15	1.43	0.43	0.72	15.91
embryonic pancreas cell line:1B2C6	10604-108F1	813.93	0.62	0.62	1.85	0.00	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	1568.95	8.17	0.30	1.51	0.30	4.54
embryonic pancreas cell line:1C3IKEI	10606-108F3	980.28	1.85	0.62	2.47	0.62	10.50
embryonic pancreas cell line:2C6	10603-108E9	994.29	2.63	0.00	3.94	0.00	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	1044.80	2.68	2.35	1.68	1.01	22.79
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1275.72	3.99	0.00	0.72	2.72	7.79
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	898.62	8.68	0.80	0.32	0.16	10.29
epidermoid carcinoma cell line:A431	10426-106D3	870.04	0.89	0.67	0.00	0.11	19.34
epidermoid carcinoma cell line:Ca Ski	10431-106D8	899.02	1.32	1.87	0.33	0.22	15.84
epididymis, adult	10197-103E8	762.94	5.65	0.21	1.88	0.42	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	616.15	1.24	0.00	0.53	2.31	4.79
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	887.15	1.97	0.00	0.00	0.00	10.62
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	946.44	3.54	1.31	0.52	0.26	9.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	793.17	1.87	0.79	0.59	0.39	7.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	864.53	2.80	0.67	0.67	0.22	10.98
esophagus, adult, pool1	10015-101C6	936.81	4.03	0.42	0.42	0.32	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1372.21	1.75	0.25	0.25	0.75	5.13
eye - muscle inferior rectus, donor1	10272-104E2	412.89	4.83	0.00	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	462.92	4.21	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	187.52	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	451.72	1.15	1.15	0.00	2.29	4.59
eye - vitreous humor, donor1	10268-104D7	549.44	1.46	0.00	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	928.46	5.59	0.76	1.78	0.25	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	766.14	1.67	0.13	1.67	0.38	19.75
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1012.12	1.66	1.19	1.42	0.24	25.17
frontal lobe, adult, pool1	10040-101F4	307.37	0.09	1.41	0.00	0.09	2.72
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	605.30	1.80	2.40	0.30	2.70	15.31
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	977.82	1.28	0.09	0.00	0.55	6.22
gall bladder, adult	10198-103E9	701.84	2.90	1.45	0.97	0.00	4.35
gamma delta positive T cells, donor1	11937-126A2	3608.74	8.05	3.22	2.68	0.54	3.76
gamma delta positive T cells, donor2	11938-126A3	2227.13	4.11	1.12	1.12	1.87	4.86
gastric adenocarcinoma cell line:MKN1	10614-108G2	815.72	7.60	0.63	2.53	0.00	15.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	2234.53	7.74	1.55	2.13	0.58	7.54
gastric cancer cell line:AZ521	10549-107H9	969.14	1.31	0.98	0.33	0.82	14.76
gastric cancer cell line:GSS	10560-108A2	1089.12	7.32	1.83	0.92	0.92	6.41
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1411.86	8.45	3.66	0.91	0.00	29.93
giant cell carcinoma cell line:LU65	10487-107B1	960.03	2.07	0.80	0.11	0.69	6.43
giant cell carcinoma cell line:Lu99B	10433-106E1	1682.31	2.52	1.12	0.42	0.42	4.06
glassy cell carcinoma cell line:HOKUG	10688-109F4	698.87	2.99	0.75	1.25	1.00	7.98
glioblastoma cell line:A172, tech_rep1	10444-106F3	300.19	0.53	0.32	0.42	0.63	5.28
glioblastoma cell line:A172, tech_rep2	10444-106F3	278.91	0.28	0.14	0.00	0.28	5.06
glioblastoma cell line:T98G	10485-107A8	830.56	2.10	0.44	0.44	0.11	11.37
glioma cell line:GI-1	10413-106B8	1396.44	1.17	0.00	0.29	0.88	11.42
globus pallidus - adult, donor10196	10175-103C4	457.03	0.00	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	550.43	1.22	0.00	0.49	0.24	2.93
globus pallidus, adult, donor10258	10367-105F7	936.54	6.85	1.37	4.11	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	588.34	2.13	0.00	0.00	0.00	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	301.00	0.00	0.00	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	4458.78	10.93	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	6852.05	15.68	0.00	0.00	0.00	26.13
granulosa cell tumor cell line:KGN	10624-108H3	395.19	5.12	0.32	0.32	0.00	7.68
hIPS +CCl2, biol_rep1	14383-156B9	1071.11	4.59	2.30	1.84	0.00	33.52
hIPS +CCl2, biol_rep2	14384-156C1	933.73	2.74	1.83	0.91	0.00	31.09
hIPS +CCl2, biol_rep3	14385-156C2	994.48	1.93	2.58	1.29	0.00	42.51
hIPS, biol_rep1	14380-156B6	228.53	5.75	5.75	0.00	0.00	61.80
hIPS, biol_rep2	14381-156B7	861.45	3.43	6.86	2.74	0.69	63.79
hIPS, biol_rep3	14382-156B8	440.28	1.10	4.41	1.10	0.00	6.62
hairy cell leukemia cell line:Mo	10712-109I1	1020.64	3.45	0.86	0.86	0.29	3.45
heart - mitral valve, adult	10205-103F7	558.77	1.79	0.00	1.49	0.00	4.19
heart - pulmonic valve, adult	10206-103F8	615.51	1.31	0.00	0.78	0.26	2.88
heart - tricuspid valve, adult	10207-103F9	264.78	0.00	0.00	0.00	1.67	8.33
heart, adult, diseased post-infarction, donor1	10050-101G5	1216.79	5.10	2.65	0.82	0.20	19.59
heart, adult, diseased, donor1	10051-101G6	555.29	2.13	0.00	0.43	0.00	5.54
heart, adult, pool1	10016-101C7	390.04	1.61	0.23	0.00	0.23	4.14
heart, fetal, pool1	10046-101G1	910.98	1.33	0.31	0.21	0.72	3.29
hepatic mesenchymal tumor cell line:LI90	10778-110G4	478.52	0.62	0.31	0.31	0.00	5.86
hepatoblastoma cell line:HuH-6	10633-108I3	1319.99	4.76	0.00	5.95	1.19	9.51
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	674.02	1.44	1.88	0.66	0.33	22.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	648.26	2.91	0.97	0.61	0.00	22.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	621.28	1.52	1.11	0.10	0.20	19.81
hepatoma cell line:Li-7	10484-107A7	921.42	2.56	1.00	0.44	1.00	20.24
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	915.76	1.81	1.01	0.70	0.10	30.95
hippocampus - adult, donor10196	10169-103B7	255.51	0.95	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	382.89	1.63	0.20	0.82	0.82	2.65
hippocampus, adult, donor10258	10374-105G5	205.16	0.50	1.99	0.50	0.00	3.49
hippocampus, newborn, donor10223	10363-105F3	256.60	1.06	1.06	0.70	0.00	6.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2994.35	52.49	3.05	1.83	0.61	126.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1192.86	7.46	1.77	2.36	0.98	49.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1461.68	11.17	2.29	0.51	0.51	47.73
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1440.67	19.17	0.56	1.69	0.56	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	2141.09	55.52	2.32	3.36	2.07	7.23
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2025.98	22.78	1.90	0.76	0.38	9.49
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1069.72	19.85	3.21	0.88	0.00	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	889.50	12.49	3.02	2.15	1.08	5.82
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	892.54	8.34	3.34	1.25	0.00	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1263.53	7.34	4.97	0.71	0.71	20.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1075.84	8.52	3.54	2.09	1.29	15.27
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1263.12	6.73	3.37	2.02	2.02	21.55
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1152.66	6.73	1.56	0.78	1.25	45.38
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	932.97	38.32	3.93	2.95	0.98	68.29
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3752.84	29.67	0.87	3.49	0.87	86.40
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1243.59	12.79	1.34	2.29	2.10	7.45
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1020.41	13.95	2.62	1.31	0.44	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1905.09	39.98	4.50	2.50	0.00	13.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1104.54	14.69	2.64	2.64	1.70	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1214.10	16.37	2.73	3.18	0.91	5.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1265.47	12.22	5.01	2.19	1.57	5.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	945.35	8.49	2.45	1.31	0.65	8.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	853.51	9.87	3.77	2.61	0.58	11.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	983.16	8.97	4.18	2.99	0.30	12.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1182.55	10.72	1.85	2.77	0.55	44.15
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	984.23	5.14	1.43	1.14	0.57	38.23
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1949.28	18.37	2.86	1.22	0.41	69.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	979.84	28.17	2.82	1.06	0.00	10.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	853.62	10.45	1.27	3.80	2.22	9.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1185.97	11.20	5.45	0.30	0.91	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	768.44	4.65	3.10	2.07	1.03	8.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	832.20	4.65	2.66	3.32	1.33	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	949.17	7.95	2.82	0.77	0.51	10.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	801.46	15.59	1.53	1.53	0.26	15.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	980.60	12.12	2.27	2.27	0.76	14.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	967.17	7.39	2.69	1.01	0.34	16.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1142.57	9.90	2.17	2.42	0.72	36.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2012.15	25.85	0.89	0.00	0.45	49.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1319.52	14.63	2.44	3.41	0.49	41.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	880.48	12.22	2.14	0.92	0.61	6.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	5572.80	182.18	0.00	9.76	0.00	68.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2129.61	39.05	1.32	1.32	0.66	15.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	866.92	13.14	1.09	2.74	0.55	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1044.04	6.51	1.09	1.09	0.36	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1125.98	12.46	1.07	0.36	0.00	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	953.51	9.55	1.19	1.19	0.00	11.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	863.34	5.96	2.57	1.08	0.68	10.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	881.73	7.00	3.23	0.00	0.00	15.89
immature langerhans cells, donor1	11904-125F5	1102.49	3.63	3.87	0.24	0.24	3.63
immature langerhans cells, donor2	11905-125F6	1309.39	4.75	0.79	5.54	0.00	4.75
insula, adult, pool1	10039-101F3	307.56	0.19	0.85	0.00	0.09	3.50
keratoacanthoma cell line:HKA-1	10791-110H8	1336.03	2.28	1.30	3.90	0.00	16.26
kidney, adult, pool1	10017-101C8	451.17	1.50	0.00	0.30	0.00	3.20
kidney, fetal, pool1	10045-101F9	626.65	0.64	0.71	0.14	0.50	1.77
large cell lung carcinoma cell line:IA-LM	10509-107D5	1295.66	1.99	1.56	0.85	1.14	18.18
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1238.51	7.05	0.55	1.24	0.14	5.53
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1118.98	1.47	1.65	0.92	0.37	5.32
left atrium, adult, donor1	10079-102A7	884.29	2.18	0.00	2.72	0.54	5.45
left ventricle, adult, donor1	10078-102A6	699.83	1.01	0.51	2.53	0.00	5.56
leiomyoblastoma cell line:G-402	10721-110A1	648.73	1.92	0.55	1.09	0.55	15.32
leiomyoma cell line:10964C	10569-108B2	749.39	9.34	0.72	1.08	0.36	7.54
leiomyoma cell line:15242A	10570-108B3	504.35	7.61	0.54	1.09	0.00	9.24
leiomyoma cell line:15425	10571-108B4	509.43	7.04	0.73	0.49	0.00	6.56
leiomyosarcoma cell line:Hs 5.T	10722-110A2	768.27	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	472.59	4.18	1.05	1.05	1.05	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1706.41	2.95	0.71	0.59	0.24	25.03
liposarcoma cell line:KMLS-1	10782-110G8	811.51	4.69	0.94	2.03	0.31	11.09
liposarcoma cell line:SW 872	10726-110A6	717.75	1.83	0.24	0.73	0.61	17.54
liver, adult, pool1	10018-101C9	676.12	1.13	0.81	0.00	0.16	5.19
liver, fetal, pool1	10086-102B5	589.83	0.94	0.00	3.76	0.00	11.29
locus coeruleus - adult, donor10196	10182-103D2	317.46	0.58	0.87	0.29	0.44	3.21
locus coeruleus, adult, donor10252	10165-103B3	388.48	2.40	0.00	0.18	0.00	2.95
locus coeruleus, adult, donor10258	10375-105G6	381.73	2.54	0.85	0.85	0.56	5.92
locus coeruleus, newborn, donor10223	10362-105F2	483.29	0.84	0.42	0.00	0.00	7.15
lung adenocarcinoma cell line:A549	10499-107C4	551.78	0.97	0.28	0.42	1.11	8.03
lung adenocarcinoma cell line:PC-14	10408-106B3	771.45	2.07	0.69	0.69	0.00	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	810.27	1.58	0.00	0.66	0.00	9.89
lung, adult, pool1	10019-101D1	785.19	1.42	0.47	0.35	0.24	1.65
lung, fetal, donor1	10068-101I5	1005.20	2.28	0.29	0.00	0.00	2.57
lung, right lower lobe, adult, donor1	10075-102A3	902.69	3.67	0.46	2.75	0.92	2.29
lymph node, adult, donor1	10077-102A5	1872.15	5.68	0.95	4.73	0.47	5.21
lymphangiectasia cell line:DS-1	10727-110A7	953.42	2.85	1.53	1.10	0.44	6.58
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1364.23	4.53	1.36	1.66	1.81	16.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	914.91	1.70	2.55	0.00	5.10	10.19
mature adipocyte, donor1	12231-129F8	581.18	1.78	0.44	0.00	0.89	4.00
mature adipocyte, donor2	12232-129F9	711.61	2.70	0.00	0.21	0.21	1.66
mature adipocyte, donor3	12233-129G1	680.84	1.90	0.00	0.00	0.00	3.08
mature adipocyte, donor4	12234-129G2	1032.60	2.63	0.00	0.00	0.26	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1062.87	1.67	2.38	0.95	0.00	7.62
medial frontal gyrus - adult, donor10196	10170-103B8	259.45	1.13	0.00	1.13	0.00	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	281.74	1.66	0.18	0.55	0.00	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	329.76	1.91	2.22	0.32	0.32	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	749.34	5.12	2.13	0.85	0.00	12.79
medial temporal gyrus - adult, donor10196	10183-103D3	350.66	3.04	0.51	1.01	0.17	5.23
medial temporal gyrus, adult, donor10252	10156-103A3	283.96	0.64	0.64	0.00	0.21	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	225.37	0.00	1.93	0.00	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	373.19	28.71	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	359.65	1.44	0.72	0.00	0.00	2.15
medulla oblongata - adult, donor10196	10174-103C3	409.51	0.00	0.00	1.30	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	354.97	1.39	0.46	0.31	0.46	1.86
medulla oblongata, adult, pool1	10038-101F2	360.47	0.57	0.33	0.00	0.00	2.61
medulla oblongata, newborn, donor10223	10361-105F1	411.41	1.74	0.69	1.39	0.00	3.82
medulloblastoma cell line:D283 Med	10838-111E1	5160.23	21.70	5.76	5.09	0.66	28.78
medulloblastoma cell line:ONS-76	10759-110E3	667.61	1.83	0.61	1.47	0.61	32.52
melanoma cell line:COLO 679	10514-107E1	400.76	1.58	0.14	0.00	0.00	14.81
melanoma cell line:G-361	10465-106H6	696.57	2.99	0.00	1.09	6.52	8.69
meningioma cell line:HKBMM	10691-109F7	1223.46	15.92	0.54	1.09	0.36	7.06
merkel cell carcinoma cell line:MKL-1	10843-111E6	1088.23	7.05	0.88	0.88	0.00	9.69
merkel cell carcinoma cell line:MS-1	10844-111E7	957.31	7.52	1.56	2.07	1.56	23.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	901.58	4.76	0.00	0.46	0.00	14.42
mesenchymal precursor cell - adipose, donor2	11748-123G2	866.00	2.00	0.00	0.36	0.00	5.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	722.61	2.90	0.00	0.83	0.00	9.52
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	745.64	2.11	0.00	0.14	0.00	4.64
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	810.13	2.89	0.00	0.58	0.00	5.01
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	605.24	2.78	0.69	0.00	0.00	4.86
mesenchymal precursor cell - cardiac, donor1	11752-123G6	807.37	4.46	0.17	0.00	0.17	4.81
mesenchymal precursor cell - cardiac, donor2	11753-123G7	776.13	3.57	0.00	0.23	0.00	6.10
mesenchymal precursor cell - cardiac, donor3	11754-123G8	727.78	3.58	0.40	0.40	0.00	10.48
mesenchymal precursor cell - cardiac, donor4	11755-123G9	640.63	3.11	0.41	0.41	0.00	10.26
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	522.25	2.13	0.00	0.28	0.00	7.40
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	558.92	2.96	0.00	0.66	0.00	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	572.03	2.91	0.00	0.28	0.00	7.20
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	502.33	2.09	0.00	0.35	0.35	7.68
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	802.57	3.27	0.41	0.20	0.00	5.92
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	416.97	2.88	0.72	0.72	0.36	4.31
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	618.53	2.59	0.00	0.21	0.00	3.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	292.51	0.91	0.46	0.23	0.46	6.61
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	674.65	3.36	0.42	0.42	0.00	11.75
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	574.14	1.94	0.15	0.15	0.00	6.72
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	614.90	3.06	0.09	0.61	0.00	5.78
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	536.78	2.95	0.37	1.10	0.00	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	382.88	2.29	0.00	0.00	0.29	3.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	769.19	11.37	0.42	0.84	0.84	14.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	587.73	2.74	0.91	0.00	0.00	7.76
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	569.38	3.33	0.51	0.51	0.26	5.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	605.70	0.52	0.26	0.52	0.26	5.76
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	587.83	3.08	0.31	0.92	0.62	7.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	636.16	6.59	0.00	0.47	0.24	7.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	600.42	2.71	0.00	0.68	0.00	7.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	644.08	2.36	0.00	0.00	0.00	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	684.42	1.39	0.00	1.39	0.00	5.10
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1014.38	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	500.40	3.46	0.00	0.58	0.00	8.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	602.37	2.23	0.00	0.45	0.00	6.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	633.09	1.68	0.72	0.48	0.00	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	465.66	8.80	0.73	0.00	0.00	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	648.15	2.01	0.00	1.01	0.00	7.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	663.60	4.09	0.00	0.41	0.00	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	688.58	2.58	0.43	2.15	0.43	9.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	669.93	5.47	0.00	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	800.57	20.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	881.47	6.82	0.65	1.30	0.00	6.17
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	739.13	8.73	0.00	2.91	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	573.59	3.73	1.07	1.07	0.00	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	657.49	8.18	0.00	0.82	0.00	9.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	699.70	5.44	0.39	1.94	0.78	7.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	738.75	4.20	0.00	0.00	0.00	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	718.28	9.93	0.99	0.99	0.00	9.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	786.59	33.37	9.53	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	817.70	10.08	0.00	1.78	0.00	7.71
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	704.27	14.62	0.00	3.66	0.00	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	649.26	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	594.11	8.23	0.00	0.00	0.00	10.77
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	821.22	3.10	0.00	2.07	1.03	8.62
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	724.28	10.75	0.00	4.30	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	798.36	7.98	0.00	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	736.99	10.33	0.00	6.89	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	730.59	6.93	0.00	2.85	0.00	4.48
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	906.46	5.56	0.00	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	814.73	6.48	0.00	0.00	0.00	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	917.97	3.74	0.00	1.25	0.62	6.23
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	851.46	13.37	0.00	2.67	0.00	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	808.95	3.55	0.00	2.37	1.18	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	947.59	10.27	0.00	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	747.60	2.75	0.00	2.75	0.00	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	734.29	3.46	0.00	0.99	0.00	4.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	659.45	2.24	0.00	1.12	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	722.57	5.09	0.00	1.27	1.27	5.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	425.95	2.01	0.00	2.01	0.00	7.25
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	750.12	4.36	0.00	6.54	0.00	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	608.19	6.34	0.00	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	549.23	1.21	0.00	0.00	0.00	9.10
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	659.77	13.56	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	522.21	4.12	0.00	0.82	0.82	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	784.18	2.78	0.20	0.99	1.59	5.56
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	535.09	3.24	0.32	1.30	0.32	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	652.94	3.06	0.00	2.04	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	499.82	1.55	0.00	0.00	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	1041.12	3.54	0.94	0.00	1.18	7.32
mesothelioma cell line:ACC-MESO-4	10494-107B8	611.16	1.39	0.46	0.93	0.93	8.11
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	841.90	0.00	0.00	0.00	0.00	25.64
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2150.05	7.19	0.00	0.62	0.10	39.87
mesothelioma cell line:Mero-25	10850-111F4	920.30	3.86	2.72	2.50	0.23	15.89
mesothelioma cell line:Mero-41	10851-111F5	688.93	5.13	0.24	0.98	0.24	6.36
mesothelioma cell line:Mero-48a	10852-111F6	625.76	1.99	0.66	1.99	0.22	10.63
mesothelioma cell line:Mero-82	10853-111F7	1756.59	5.52	3.68	3.94	0.26	61.50
mesothelioma cell line:Mero-83	10854-111F8	770.08	2.55	0.51	1.53	0.00	13.62
mesothelioma cell line:Mero-84	10855-111F9	749.47	4.55	0.51	1.52	0.25	15.67
mesothelioma cell line:Mero-95	10856-111G1	990.91	4.97	1.45	1.04	0.00	14.08
mesothelioma cell line:NCI-H2052	10847-111F1	1337.77	4.80	1.33	2.48	0.17	24.18
mesothelioma cell line:NCI-H226	10846-111E9	869.48	2.90	0.54	1.81	0.18	34.75
mesothelioma cell line:NCI-H2452	10848-111F2	587.29	1.88	0.17	1.88	0.17	8.88
mesothelioma cell line:NCI-H28	10845-111E8	622.42	2.29	0.76	0.76	0.00	3.82
mesothelioma cell line:No36	10857-111G2	679.81	3.59	0.33	1.30	0.00	10.44
mesothelioma cell line:ONE58	10858-111G3	410.49	1.08	0.54	0.81	0.27	5.15
migratory langerhans cells, donor1	11901-125F2	530.47	2.49	0.38	0.38	0.19	1.54
migratory langerhans cells, donor2	11902-125F3	292.34	1.47	0.73	0.12	0.12	1.10
migratory langerhans cells, donor3	11903-125F4	499.49	1.26	0.36	0.36	0.18	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	1435.86	24.16	1.31	1.63	1.96	22.85
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	737.54	6.78	1.06	3.18	0.00	33.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	829.52	1.15	1.15	2.07	0.46	29.72
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	752.42	1.90	0.38	0.76	0.19	4.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2666.74	8.13	1.66	1.11	3.70	19.03
myeloma cell line:PCM6	10474-106I6	1354.02	3.56	1.58	0.59	3.36	5.53
myxofibrosarcoma cell line:MFH-ino	10600-108E6	317.56	2.54	0.00	1.01	0.00	14.71
myxofibrosarcoma cell line:NMFH-1	10684-109E9	892.43	3.53	0.59	0.39	0.00	11.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	993.46	1.23	0.45	0.45	0.00	4.57
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1221.29	2.79	0.59	0.29	0.07	5.59
nasal epithelial cells, donor2	12227-129F4	554.75	0.55	1.10	0.55	0.00	4.42
neuroblastoma cell line:CHP-134	10508-107D4	1564.87	0.92	1.15	0.00	2.30	5.29
neuroblastoma cell line:NB-1	10539-107G8	782.02	0.94	0.75	0.19	0.56	14.03
neuroblastoma cell line:NBsusSR	10607-108F4	1193.21	5.90	1.48	1.05	0.42	20.46
neuroblastoma cell line:NH-12	10555-107I6	2025.64	4.66	0.93	0.93	0.19	5.78
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1576.13	7.12	1.90	1.90	0.24	3.80
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1766.74	6.34	0.79	3.17	0.79	6.65
neuroectodermal tumor cell line:TASK1	10774-110F9	1482.48	3.62	0.40	2.01	0.40	16.70
neuroepithelioma cell line:SK-N-MC	10728-110A8	1064.91	1.27	0.00	2.54	2.54	21.62
neurofibroma cell line:Hs 53.T	10729-110A9	514.77	1.60	0.00	1.06	0.27	15.44
neutrophil PMN, donor1	12133-128D9	282.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	1367.91	0.00	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	1562.65	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1840.88	2.03	0.17	0.34	0.85	11.16
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2281.45	3.20	4.00	0.00	0.00	54.43
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1171.49	5.45	0.00	2.56	0.64	11.54
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	613.55	4.20	0.79	0.53	0.00	6.57
nucleus accumbens, adult, pool1	10037-101F1	324.90	0.00	0.94	0.09	0.09	2.06
occipital cortex - adult, donor10196	10172-103C1	243.13	2.06	0.00	0.00	0.00	8.24
occipital cortex, adult, donor10252	10163-103B1	329.01	1.61	0.27	0.54	0.81	3.22
occipital cortex, newborn, donor10223	10355-105E4	343.56	1.09	1.46	0.36	0.00	4.37
occipital lobe, adult, donor1	10076-102A4	399.63	3.15	0.26	0.79	0.26	6.30
occipital lobe, fetal, donor1	10073-102A1	1700.52	9.01	0.43	2.15	0.86	5.58
occipital pole, adult, pool1	10036-101E9	204.12	0.08	0.95	0.16	0.00	1.97
olfactory region, adult	10195-103E6	291.55	0.76	0.96	0.00	0.19	2.67
optic nerve, donor1	10277-104E7	508.27	10.01	0.00	2.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1378.86	2.62	6.95	0.23	0.11	8.88
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1520.87	1.79	1.24	0.82	0.69	11.54
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	891.83	9.99	0.85	0.85	0.34	13.55
oral squamous cell carcinoma cell line:SAS	10544-107H4	1812.10	4.97	1.73	1.27	0.12	17.21
osteoclastoma cell line:Hs 706.T	10704-109H2	445.07	2.06	0.29	0.88	0.00	5.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1690.21	0.93	0.00	0.00	0.93	12.15
osteosarcoma cell line:HS-Os-1	10558-107I9	7043.75	12.09	5.09	0.85	4.24	81.64
ovary, adult, pool1	10020-101D2	1437.02	2.18	0.09	0.26	0.09	1.75
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	630.99	1.28	0.55	1.28	0.37	27.13
pancreas, adult, donor1	10049-101G4	1947.12	15.05	0.00	1.88	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1257.07	2.52	3.07	1.68	0.84	8.39
papillary adenocarcinoma cell line:8505C	10437-106E5	1228.76	14.65	1.36	1.36	0.17	8.35
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	864.67	1.32	0.83	0.50	0.17	3.64
paracentral gyrus, adult, pool1	10035-101E8	247.29	0.37	0.64	0.00	0.27	2.29
parietal cortex, adult, donor10258	10373-105G4	317.09	0.00	2.20	0.00	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	294.37	0.94	0.00	4.70	0.00	3.76
parietal lobe, adult, donor10252	10157-103A4	282.47	0.86	0.29	0.57	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	263.13	0.18	0.88	0.09	0.09	2.91
parietal lobe, fetal, donor1	10072-101I9	2304.33	2.91	0.00	5.82	0.97	7.76
parietal lobe, newborn, donor10223	10356-105E5	376.85	0.37	3.74	0.75	0.37	2.99
parotid gland, adult	10199-103F1	945.35	2.47	0.00	0.62	0.00	1.85
penis, adult	10200-103F2	754.11	5.91	0.00	0.54	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2538.21	9.48	0.56	2.05	0.74	5.95
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1291.44	3.93	2.33	0.73	0.29	21.85
pineal gland - adult, donor10196	10179-103C8	158.03	0.00	1.29	0.00	0.00	3.23
pineal gland, adult, donor10252	10160-103A7	205.50	0.59	0.00	0.00	0.00	2.37
pineal gland, adult, donor10258	10377-105G8	249.58	0.00	1.25	1.25	0.63	4.39
pituitary gland - adult, donor10196	10180-103C9	723.44	5.06	5.06	2.02	0.00	5.06
pituitary gland, adult, donor10252	10162-103A9	384.63	0.52	0.52	0.52	1.04	7.30
pituitary gland, adult, donor10258	10378-105G9	953.39	3.40	0.85	1.70	0.85	4.26
placenta, adult, pool1	10021-101D3	560.52	1.08	0.43	0.00	0.11	3.12
plasma cell leukemia cell line:ARH-77	10840-111E3	2010.11	4.90	0.40	0.66	0.66	12.98
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	473.77	1.25	0.16	0.47	0.31	1.71
pons, adult, pool1	10033-101E6	236.34	0.17	0.77	0.09	0.00	1.98
postcentral gyrus, adult, pool1	10032-101E5	287.42	0.35	0.78	0.00	0.35	2.27
promyelocytes/myelocytes PMC, donor1	12132-128D8	173.59	0.00	0.00	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	5987.24	11.02	0.00	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	6184.74	0.00	0.00	11.74	0.00	23.47
prostate cancer cell line:DU145	10490-107B4	1078.77	5.10	0.15	0.58	0.87	10.49
prostate cancer cell line:PC-3	10439-106E7	1616.27	3.81	2.72	0.91	6.35	29.40
prostate, adult, pool1	10022-101D4	993.26	1.72	0.18	0.36	0.36	1.45
putamen, adult, donor10196	10176-103C5	409.57	1.18	1.42	0.24	0.24	4.49
putamen, adult, donor10252	10152-102I8	862.72	3.92	0.00	3.92	0.00	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	454.61	2.19	2.19	2.19	0.00	17.48
putamen, adult, donor10258, tech_rep2	10372-105G3	337.05	0.72	2.42	0.48	0.24	3.62
putamen, newborn, donor10223	10365-105F5	721.92	1.50	0.75	0.75	0.00	12.74
rectal cancer cell line:TT1TKB	10469-106I1	1255.97	0.87	0.58	1.16	1.75	6.98
rectum, fetal, donor1	10067-101I4	1290.84	2.78	0.00	0.00	0.00	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	374.18	0.85	0.00	0.42	0.00	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	730.67	4.14	0.00	0.00	2.07	0.83
retina, adult, pool1	10030-101E3	523.34	0.89	1.19	0.20	0.10	0.80
retinoblastoma cell line:Y79	10475-106I7	1465.02	2.86	2.08	0.00	0.78	12.21
rhabdomyosarcoma cell line:KYM-1	10787-110H4	603.80	1.35	0.86	1.60	0.61	22.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2060.92	2.53	0.84	0.56	2.25	46.96
sacrococcigeal teratoma cell line:HTST	10695-109G2	653.27	2.27	0.00	1.52	1.52	3.79
salivary acinar cells, donor1	11771-123I7	947.18	2.91	0.49	0.32	0.16	4.86
salivary acinar cells, donor2	11772-123I8	1282.56	4.41	0.55	0.83	0.14	3.44
salivary acinar cells, donor3	11773-123I9	595.85	0.00	0.00	0.66	0.00	1.32
salivary gland, adult, pool1	10093-102C3	1368.68	1.72	0.00	1.14	0.57	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	712.26	1.52	0.42	0.17	0.42	2.53
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	733.17	1.53	0.71	0.71	2.35	4.11
seminal vesicle, adult	10201-103F3	857.62	5.82	0.53	6.88	0.53	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1011.30	12.15	0.73	0.97	0.00	19.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	601.40	3.02	0.25	1.26	0.50	3.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	673.37	3.01	0.00	1.00	0.00	12.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	934.07	2.28	1.07	0.40	0.00	5.37
signet ring carcinoma cell line:Kato III	10436-106E4	632.55	0.99	1.22	0.22	0.33	4.31
signet ring carcinoma cell line:NUGC-4	10483-107A6	787.44	1.81	0.26	0.13	0.77	6.58
skeletal muscle - soleus muscle, donor1	10282-104F3	685.93	1.42	0.00	0.71	0.71	3.55
skeletal muscle, adult, pool1	10023-101D5	1164.47	2.04	0.24	0.72	0.60	3.96
skeletal muscle, fetal, donor1	10066-101I3	2841.18	10.05	0.00	7.04	1.01	8.04
skin, adult, donor1	10074-102A2	1445.25	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	1466.34	19.57	0.63	3.79	1.26	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	558.32	1.33	2.33	1.33	0.67	15.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	2059.87	9.77	4.41	2.84	0.32	18.60
small cell lung carcinoma cell line:DMS 144	10841-111E4	2601.32	8.87	0.19	2.12	0.58	10.41
small cell lung carcinoma cell line:LK-2	10541-107H1	1707.77	2.80	5.77	0.33	0.66	12.53
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1906.07	3.22	0.16	1.61	0.32	4.02
small cell lung carcinoma cell line:WA-hT	10562-108A4	852.06	1.31	3.49	1.09	0.22	22.66
small intestine, adult, pool1	10024-101D6	626.12	0.96	0.48	0.12	0.84	2.75
small intestine, fetal, donor1	10064-101I1	1594.81	5.16	0.00	2.70	0.25	8.60
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	771.40	13.34	0.51	1.03	0.51	7.69
smooth muscle, adult, pool1	10048-101G3	887.28	2.07	0.00	2.07	0.00	2.07
somatostatinoma cell line:QGP-1	10781-110G7	409.54	0.80	0.54	0.27	0.27	5.90
spinal cord - adult, donor10196	10181-103D1	565.71	3.21	0.00	0.92	0.23	2.52
spinal cord, adult, donor10252	10159-103A6	396.24	0.39	0.00	0.00	0.39	1.18
spinal cord, adult, donor10258	10369-105F9	915.25	1.38	0.00	2.08	0.00	4.84
spinal cord, fetal, donor1	10056-101H2	697.04	4.88	0.61	0.61	0.61	4.27
spinal cord, newborn, donor10223	10359-105E8	418.34	2.30	0.00	2.30	0.00	5.97
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	377.57	1.05	0.15	0.45	0.45	8.21
spleen, adult, pool1	10025-101D7	878.32	1.98	0.44	0.33	0.22	2.64
spleen, fetal, pool1	10044-101F8	602.35	0.79	0.32	0.24	0.32	1.99
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	935.23	1.86	1.24	0.21	0.21	7.35
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1210.08	1.14	0.38	0.76	3.61	9.49
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	2130.26	11.53	7.69	2.80	0.00	46.13
squamous cell carcinoma cell line:T3M-5	10616-108G4	1413.22	7.43	1.95	3.52	0.39	24.24
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	800.29	1.58	2.81	0.11	0.90	16.32
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1494.89	4.66	4.24	2.97	0.00	16.94
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	564.38	0.42	0.42	0.00	0.42	9.73
stomach, fetal, donor1	10062-101H8	1006.03	2.14	0.00	4.27	1.07	12.82
submaxillary gland, adult	10202-103F4	1248.17	9.11	0.00	2.28	0.00	4.56
substantia nigra - adult, donor10196	10178-103C7	976.93	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	563.71	4.36	0.00	0.62	0.00	2.28
substantia nigra, adult, donor10258	10371-105G2	355.35	0.00	0.52	0.52	0.00	2.07
substantia nigra, newborn, donor10223	10358-105E7	503.79	1.41	0.71	0.00	0.00	7.07
synovial sarcoma cell line:HS-SY-II	10441-106E9	1350.37	2.98	1.60	0.69	3.21	20.63
temporal lobe, adult, pool1	10031-101E4	268.64	0.42	0.76	0.25	0.17	2.54
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1793.49	18.52	0.71	3.56	1.42	8.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1239.94	7.47	0.00	2.20	1.32	5.71
tenocyte, donor1	11763-123H8	583.35	5.24	0.70	0.70	0.00	5.59
tenocyte, donor2	11765-123I1	737.45	3.82	0.00	0.76	0.00	4.58
tenocyte, donor3	11768-123I4	672.39	6.67	0.74	1.48	0.37	5.19
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	969.45	4.93	1.70	1.36	0.17	32.12
teratocarcinoma cell line:NCR-G1	10798-110I6	977.76	3.85	1.08	2.31	0.92	27.59
teratocarcinoma cell line:PA-1	10807-111A6	982.71	1.39	0.93	1.70	0.31	32.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1526.67	5.59	2.67	1.40	1.14	19.55
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1113.34	1.51	1.13	1.51	0.38	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1735.29	6.87	1.53	0.55	0.44	7.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1526.89	19.87	1.95	0.98	0.33	14.01
testis, adult, pool1	10026-101D8	802.07	2.25	5.26	0.11	1.50	3.97
testis, adult, pool2	10096-102C6	703.69	3.61	20.75	2.26	0.00	4.06
thalamus - adult, donor10196	10168-103B6	383.08	1.10	0.00	1.10	0.00	5.52
thalamus, adult, donor10252	10154-103A1	482.76	1.09	0.00	0.31	0.16	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	278.67	0.00	0.00	0.00	0.00	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	346.84	1.48	0.33	0.99	0.00	3.13
thalamus, newborn, donor10223	10366-105F6	300.89	0.00	1.73	0.00	0.00	11.51
throat, adult	10209-103G2	514.32	5.99	0.00	0.75	0.75	3.75
throat, fetal, donor1	10061-101H7	1266.66	8.23	0.61	1.83	1.22	5.18
thymic carcinoma cell line:Ty-82	10803-111A2	1006.18	1.39	1.79	0.79	0.60	19.28
thymus, adult, pool1	10027-101D9	1124.08	2.39	1.89	0.70	1.09	4.87
thymus, fetal, pool1	10043-101F7	845.78	1.25	0.83	0.21	0.42	4.05
thyroid carcinoma cell line:KHM-5M	10776-110G2	1772.50	5.05	1.73	2.66	0.27	37.89
thyroid carcinoma cell line:TCO-1	10783-110G9	2138.80	4.47	0.98	2.51	0.70	17.32
thyroid, adult, pool1	10028-101E1	1207.75	3.08	0.19	0.28	1.40	3.45
thyroid, fetal, donor1	10060-101H6	740.10	0.79	1.05	0.79	0.79	6.06
tongue epidermis (fungiform papillae), donor1	10288-104F9	354.16	0.00	0.00	9.24	3.08	12.32
tongue, adult	10203-103F5	552.14	7.21	0.23	1.63	0.23	4.65
tongue, fetal, donor1	10059-101H5	1797.06	7.49	0.00	4.34	0.00	9.85
tonsil, adult, pool1	10047-101G2	1123.07	0.80	1.10	0.30	0.60	4.21
trachea, adult, pool1	10029-101E2	745.92	1.47	0.65	0.25	0.57	3.44
trachea, fetal, donor1	10058-101H4	986.36	5.77	2.31	3.08	1.92	7.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	677.37	2.83	0.35	0.71	0.00	18.07
transitional-cell carcinoma cell line:5637	10418-106C4	752.58	0.71	0.81	0.20	0.00	10.94
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1639.10	4.07	2.19	0.94	1.57	8.62
tridermal teratoma cell line:HGRT	10694-109G1	323.43	3.81	1.90	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1600.32	3.89	1.27	1.78	0.68	6.86
umbilical cord, fetal, donor1	10057-101H3	1007.78	4.17	0.00	0.00	0.00	8.35
uterus, adult, pool1	10100-102D1	1172.05	1.54	0.00	0.00	0.51	1.88
uterus, fetal, donor1	10055-101H1	1242.45	6.14	0.51	5.12	1.02	3.58
vagina, adult	10204-103F6	1086.91	2.58	0.00	1.29	0.65	0.00
vein, adult	10191-103E2	1289.76	5.04	0.44	0.88	0.22	3.73
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1119.42	3.74	0.00	2.14	0.00	4.01